 |
市場調查報告書
商品編碼
1516507
全球高通量篩檢(HTS) 市場：市場規模、佔有率、趨勢 - 按產品、按應用、按技術、按最終用戶、按地區 - 預測至 2029 年High Throughput Screening Market / HTS Market Size, Share & Trends by Offering (Instruments, Consumables, Software, Services), Technology, Application - Global Forecast to 2029 |
||||||
價格
全球高通量篩檢市場規模預計將從 2024 年的 288 億美元增至 2029 年的 502 億美元，預測期內複合年成長率為 11.8%。
製藥和生物技術公司可以透過與學術機構、研究機構和技術供應商合作，利用高通量篩檢(HTS) 的外部專業知識和新技術。例如，2023 年，ChemDiv, Inc.（美國）將與德克薩斯大學醫學分部 (UTMB) 合作，擴大其庫存並推進其高通量篩檢(HTS) 研究計畫。此外，佛羅裡達大學健康學院（美國）等研究機構正在與各種高通量篩檢應用的研究小組合作，包括測定開發、試點篩檢和 HTS宣傳活動。同樣，諾華公司（瑞士）等主要製藥公司在2023年投資了36.4億美元用於探索性研究，以發現和開發候選藥物。這筆投資金額比上年成長24%。隨著製藥公司和研究機構投入更多資源進行研發，對高通量篩檢（HTS）等高效能藥物發現技術的需求預計將會增加。
| 調查範圍 | |
|---|---|
| 調查年份 | 2022-2029 |
| 基準年 | 2023年 |
| 預測期 | 2024-2029 |
| 考慮單位 | 金額（美元） |
| 按細分市場 | 按產品、按應用、按技術、按最終用戶、按地區 |
| 目標區域 | 北美、歐洲、亞太地區、拉丁美洲 (LATAM)、中東/非洲 |
透過提供的產品，高通量篩檢(HTS) 市場分為消耗品、設備、服務和軟體。高通量篩檢(HTS) 市場的服務包括高通量篩檢服務、檢測開發服務、細胞株開發服務和微孔盤開發服務。這些服務對於高通量篩檢至關重要，因為它們提供了有效的藥物發現和生命科學研究所需的工具和流程。藥物發現和命中鑑定分析的複雜性不斷增加，以及對具有成本效益和專業的高通量篩檢(HTS) 專業知識的需求不斷增加等因素正在推動服務領域的成長。服務供應商還可以降低研究和監管風險，幫助製藥和生物技術公司專注於其核心競爭力。由於這些因素，高通量篩檢（HTS）服務業已成為該公司利潤豐厚的市場，並在預測期內創下了市場最高成長率。
按最終用戶分類，高通量篩檢(HTS) 市場分為製藥和生技公司、學術和研究機構、CRO 和其他最終用戶。預計合約研究組織 (CRO) 在預測期內將呈現最高成長率。這種成長的部分原因是製藥和生技公司將其研發活動外包給 CRO 等研究機構的趨勢日益明顯。高通量篩檢(HTS) 使 CRO 能夠針對特定標靶快速篩檢大型化合物庫，從而更有效地尋找先導化合物。透過及早識別不合適的化合物，CRO 可以為其製藥客戶降低成本和風險，節省時間和金錢，並將後期失敗的風險降至最低。 CRO 投資了先進的 HTS 技術和基礎設施，使他們能夠執行小型企業無法完成的複雜篩檢。例如，Labcorp的藥物開發服務使用機器人篩檢系統，Parexel將人工智慧和機器學習整合到HTS中以增強篩檢能力。
該報告研究了全球高通量篩檢(HTS) 市場，包括按產品、應用、技術、最終用戶、地區和參與市場的公司概況分類的趨勢。
目錄
第1章簡介
第2章調查方法
第3章執行摘要
第 4 章重要考察
第5章市場概況
- 介紹
- 市場動態
- 產業動態
- 技術分析
- 影響客戶業務的趨勢/干擾
- 價格分析
- 價值鏈分析
- 供應鏈分析
- 生態系分析
- 專利分析
- 貿易分析
- 監管分析
- 波特五力分析
- 2024-2025年重大會議和活動
- 主要相關人員和採購標準
第6章高通量篩檢(HTS) 市場（依產品）
- 介紹
- 消耗品
- 裝置
- 服務
- 軟體
第7章高通量篩檢(HTS) 市場（依應用）
- 介紹
- 藥物發現
- 生化篩檢
- 生命科學研究
- 其他
第8章高通量篩檢(HTS) 市場（按技術）
- 介紹
- 細胞化驗分析
- 實驗室晶片
- 無標定技術
第 9 章 高通量篩檢(HTS) 市場（依最終使用者）
- 介紹
- 製藥和生物技術公司
- 學術研究所
- CRO
- 其他
第 10 章高通量篩檢(HTS) 市場（按地區）
- 介紹
- 北美洲
- 歐洲
- 亞太地區
- 拉丁美洲
- 中東
- 非洲
第11章競爭格局
- 概述
- 主要參與企業的策略/秘密
- 收益分析
- 市場佔有率分析
- 企業評估矩陣：主要參與企業，2023
- 企業評估矩陣：Start-Ups/小型企業，2023 年
- 公司評價及財務指標
- 品牌/產品比較
- 競爭場景
第12章 公司簡介
- 主要參與企業
- THERMO FISHER SCIENTIFIC INC.
- AGILENT TECHNOLOGIES, INC.
- MERCK KGAA
- DANAHER CORPORATION
- REVVITY, INC.
- TECAN GROUP LTD.
- BIO-RAD LABORATORIES, INC.
- CORNING INCORPORATED
- METTLER-TOLEDO INTERNATIONAL INC.
- LONZA GROUP
- WATERS CORPORATION
- SARTORIUS AG
- EPPENDORF SE
- PORVAIR PLC
- GREINER AG
- CHARLES RIVER LABORATORIES
- EUROFINS SCIENTIFIC
- HAMILTON COMPANY
- AURORA BIOMED INC.
- GILSON INCORPORATED
- BRAND GMBH+CO KG
- 其他公司
- BMG LABTECH GMBH
- DIANA BIOTECHNOLOGIES, AS
- CREATIVE BIOLABS
- HIGHRES BIOSOLUTIONS
- BIOMAT SRL
- AXXAM SPA
- SYGNATURE DISCOVERY LIMITED
- CROWN BIOSCIENCE
第13章附錄
Product Code: BT 2220
The global high-throughput screening market size is projected to reach USD 50.2 billion by 2029 from USD 28.8 billion in 2024, at a CAGR of 11.8% during the forecast period. Pharmaceutical & biotechnology companies collaborate with academic institutions, research organizations, and technology providers, enabling them to access external expertise and novel technologies in high-throughput screening (HTS). For instance, in 2023, ChemDiv, Inc. (US) collaborated with the University of Texas Medical Branch (UTMB) to expand its inventory and advance its high throughput screening (HTS) research programs. Furthermore, institutions such as the University of Florida Health (US) collaborate with research groups for various high-throughput screening applications, including assay development, pilot screening, and HTS campaigns. The university's High Throughput Molecular Screening Center supports researchers by providing grant support for their research Similarly, major pharmaceutical companies, such as Novartis AG (Switzerland), invested USD 3.64 billion in 2023, for exploratory research to discover and develop new drug candidates. This investment was 24% higher than the previous year's investment. With the increased allocation of resources to research and development by pharmaceutical companies and research institutions, there will be a growing demand for efficient and effective drug discovery technologies like high throughput screening (HTS).
| Scope of the Report | |
|---|---|
| Years Considered for the Study | 2022-2029 |
| Base Year | 2023 |
| Forecast Period | 2024-2029 |
| Units Considered | Value (USD) |
| Segments | By Offerings, Application, Technology, and End User |
| Regions covered | North America, Europe, Asia Pacific, Latin America (LATAM), Middle East and Africa |
"The services segment is set to register highest growth rate during 2024-2029 in the high throughput screening (HTS) market"
The high-throughput screening (HTS) offerings market is segmented into consumables, instruments, services, and software. Services in the high-throughput screening (HTS) market include high-throughput screening services, assay development services, cell line development services, and microplate development services. These services are essential for high-throughput screening as they offer tools and processes necessary for effective drug discovery and life science research. Factors such as increasing assay complexities for drug development and hit identification, along with the growing demand for cost-effective and specialized high-throughput screening (HTS) expertise drive the growth of the service segment. Service providers also help mitigate research and regulatory risks and allow pharmaceutical and biotechnology companies to focus on their core competencies. Owing to these factors, the high-throughput screening (HTS) services segment has emerged as a beneficial market space for companies and registered the highest growth rate in the market during the forecast period.
"CRO end user segment is set to witness the highest growth rate in the HTS market"
Based on end user, the high-throughput screening market is segmented into pharmaceutical & biotechnology companies, academic & research institutes, contract research organizations (CROs), and other end users. Contract Research Organizations (CROs) are projected to witness the highest growth rate during the forecast period. This growth can be attributed to factors such as the growing trend of outsourcing of R&D activities by pharmaceutical and biotechnology companies to research organizations such as CROs. High throughput screening (HTS) allows CROs to rapidly screen large libraries of compounds against specific targets, making lead discovery more efficient. By identifying unsuitable compounds early, CROs can reduce costs and risks for their pharmaceutical clients, saving time and money and minimizing the risk of late-stage failures. CROs are investing in advanced HTS technologies and infrastructure, allowing them to perform complex screens not feasible for smaller companies. For instance, Labcorp Drug Development services use robotic screening systems, and Parexel integrates AI and machine learning with HTS to enhance their screening capabilities
"Drug Discovery segment accounted for the highest CAGR"
Based on application, the high-throughput screening (HTS) market is segmented into drug discovery, biochemical screening, life sciences research, and other applications. The drug discovery segment is projected to grow with the highest CAGR throughout 2024 to 2029. The key factor driving this segment's growth is the increasing prevalence of diseases leading to a rise in pharmaceutical drug discovery research and development. Pharmaceutical companies are utilizing this technology for lead discovery, target validation, primary screening, compound profiling, and hit identification Additionally, ongoing advancements such as automation and AI integration, in high-throughput screening (HTS) technologies further aid in making the drug discovery process more efficient and cost-effective supporting the growth of the market.
"Asia Pacific: The fastest-growing country in the high-throughput screening market"
The high-throughput screening (HTS) market is segmented into North America, Europe, Asia Pacific, Latin America, Middle East and Africa. Asia Pacific is projected to register the highest CAGR during the forecast period. Factors such as rising pharmaceutical R&D spending, growing public-private partnerships, and increasing government funding drive the growth of the HTS market in this region.
The primary interviews conducted for this report can be categorized as follows:
- By Respondent: Supply Side -80% and Demand Side - 20%
- By Designation: Managers -45%, CXOs and Directors -30%, and Executives - 25%
- By Region: North America-55%, Europe -15%, Asia-Pacific -15%, Latin America-10%, Middle East and Africa-5%
Lists of Companies Profiled in the Report:
- Thermo Fisher Scientific Inc. (US)
- Agilent Technologies, Inc. (US)
- Merck KGaA (Germany)
- Danaher Corporation (US)
- Revvity, Inc. (US)
- Tecan Group Ltd. (Switzerland)
- Bio-Rad Laboratories, Inc. (US)
- Corning Incorporated (US)
- Mettler-Toledo International Inc. (US)
- Lonza Group (Switzerland)
- Waters Corporation (US)
- Sartorius AG (Germany)
- Eppendorf SE (Germany)
- Porvair Plc (UK)
- Greiner AG (Austria)
- Charles River Laboratories (US)
- Eurofins Scientific (Luxembourg)
- Hamilton Company (US)
- Aurora Biomed Inc. (Canada)
- Gilson Incorporated (US)
- Brand GmbH+Co KG (Germany)
- BMG Labtech GmbH (Germany)
- DIANA Biotechnologies (Czechia)
- A.S. (Czech Republic)
- Creative Biolabs (US)
- HighRes Biosolutions (US)
- Biomat Srl, (Italy)
- Axxam S.p.A. (Italy)
- Sygnature Discovery Limited (UK)
- Crown Bioscience (US)
Research Coverage:
This report provides a detailed picture of the high throughput screening market. It aims at estimating the size and future growth potential of the market across different segments, such as offerings, technology, application, end user, and region. The report also includes an in-depth competitive analysis of the key market players, along with their company profiles, recent developments, and key market strategies.
Reasons to Buy the Report:
The report provides insights on the following pointers:
- Analysis of key drivers (the growing adoption of open innovative models in pharmaceutical & biotechnology companies, rising government funding and venture capital investments, increasing R&D spending, and technological advancements), restraints (high costs of using HTS instruments), opportunities (increasing adoption of HTS technologies in emerging markets, growing research on novel therapeutics and application of HTS technology in drug repurposing), and challenges (lack of skilled operators, and complexities in data management, assay development, and analysis) influencing the growth of the high throughput screening (HTS) market.
- Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product & service launches in the high throughput screening (HTS) market.
- Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various high-throughput screening opportunities and developments across key geographic regions.
- Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the high-throughput screening (HTS) market.
- Competitive Assessment: In-depth assessment of market ranking and strategies of the leading players like Thermo Fisher Scientific Inc. (US), Agilent Technologies, Inc. (US), Merck KGaA (Germany), Danaher Corporation (US), Revvity, Inc. (US), among others in the high-throughput screening market.
TABLE OF CONTENTS
1 INTRODUCTION
- 1.1 STUDY OBJECTIVES
- 1.2 MARKET DEFINITION
- 1.2.1 INCLUSIONS & EXCLUSIONS
- 1.3 MARKET SCOPE
- 1.3.1 SEGMENTS COVERED
- 1.3.2 REGIONS COVERED
- 1.3.3 YEARS CONSIDERED
- 1.4 CURRENCY CONSIDERED
- 1.5 LIMITATIONS
- 1.6 STAKEHOLDERS
- 1.7 SUMMARY OF CHANGES
- 1.7.1 RECESSION IMPACT
2 RESEARCH METHODOLOGY
- 2.1 RESEARCH DATA
- 2.1.1 SECONDARY DATA
- 2.1.2 PRIMARY DATA
- 2.2 MARKET SIZE ESTIMATION
- 2.2.1 INSIGHTS FROM PRIMARIES
- 2.3 MARKET GROWTH FORECAST
- 2.4 MARKET BREAKDOWN & DATA TRIANGULATION
- 2.5 RESEARCH ASSUMPTIONS
- 2.6 RISK ANALYSIS
- 2.7 RECESSION IMPACT ON HIGH-THROUGHPUT SCREENING (HTS) MARKET
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
- 4.1 HIGH-THROUGHPUT SCREENING (HTS) MARKET OVERVIEW
- 4.2 NORTH AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET SHARE, BY OFFERING AND COUNTRY (2023)
- 4.3 HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY OFFERING, 2024 VS. 2029 (USD MILLION)
- 4.4 HIGH-THROUGHPUT SCREENING (HTS) MARKET SHARE, BY END USER, 2023
- 4.5 HIGH-THROUGHPUT SCREENING (HTS) MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
5 MARKET OVERVIEW
- 5.1 INTRODUCTION
- 5.2 MARKET DYNAMICS
- 5.2.1 DRIVERS
- 5.2.1.1 Growing adoption of open innovation models
- 5.2.1.2 Rising government funding and venture capital investments
- 5.2.1.3 Increasing R&D spending
- 5.2.1.4 Technological advancements
- 5.2.2 RESTRAINTS
- 5.2.2.1 High cost of using HTS instruments
- 5.2.3 OPPORTUNITIES
- 5.2.3.1 Increasing adoption of HTS technologies in emerging markets
- 5.2.3.2 Growing research on novel therapeutics
- 5.2.3.3 Drug repurposing
- 5.2.4 CHALLENGES
- 5.2.4.1 Lack of skilled operators
- 5.2.4.2 Complexities in data management, assay development, and analysis
- 5.2.1 DRIVERS
- 5.3 INDUSTRY TRENDS
- 5.3.1 ADOPTION OF PHENOTYPIC SCREENING
- 5.3.2 AUTOMATION AND AI INTEGRATION
- 5.3.3 RISE OF CRISPR TECHNOLOGY
- 5.3.4 INTEGRATION OF SINGLE-CELL ANALYSIS TECHNOLOGIES
- 5.3.5 REGULATORY CONSIDERATIONS
- 5.4 TECHNOLOGY ANALYSIS
- 5.4.1 KEY TECHNOLOGIES
- 5.4.1.1 High-content screening/analysis
- 5.4.1.2 Label-free detection (surface plasmon resonance)
- 5.4.2 COMPLEMENTARY TECHNOLOGIES
- 5.4.2.1 Microfluidics, organ-on-a-chip (OOC), and lab-on-a-chip (LOC)
- 5.4.2.2 Mass spectrometry (MS)
- 5.4.2.3 Flow cytometry
- 5.4.3 ADJACENT TECHNOLOGIES
- 5.4.3.1 Fragment-based drug discovery
- 5.4.1 KEY TECHNOLOGIES
- 5.5 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
- 5.6 PRICING ANALYSIS
- 5.7 VALUE CHAIN ANALYSIS
- 5.8 SUPPLY CHAIN ANALYSIS
- 5.9 ECOSYSTEM ANALYSIS
- 5.9.1 HIGH-THROUGHPUT SCREENING MARKET: ROLE OF RAW MATERIAL VENDORS
- 5.9.2 HIGH-THROUGHPUT SCREENING MARKET: ROLE OF PRODUCT & SERVICE PROVIDERS
- 5.9.3 HIGH-THROUGHPUT SCREENING MARKET: ROLE OF END USERS
- 5.9.4 HIGH-THROUGHPUT SCREENING MARKET: ROLE OF REGULATORY AUTHORITIES
- 5.1 PATENT ANALYSIS
- 5.11 TRADE ANALYSIS
- 5.11.1 IMPORT DATA FOR SPECTROMETERS
- 5.11.2 IMPORT DATA FOR MASS SPECTROMETERS
- 5.11.3 EXPORT DATA FOR SPECTROMETERS
- 5.11.4 EXPORT DATA FOR MASS SPECTROMETERS
- 5.12 REGULATORY ANALYSIS
- 5.12.1 REGULATORY LANDSCAPE
- 5.12.1.1 US
- 5.12.1.2 Europe
- 5.12.1.3 Emerging markets
- 5.12.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
- 5.12.1 REGULATORY LANDSCAPE
- 5.13 PORTER'S FIVE FORCES ANALYSIS
- 5.13.1 INTENSITY OF COMPETITIVE RIVALRY
- 5.13.2 BARGAINING POWER OF SUPPLIERS
- 5.13.3 BARGAINING POWER OF BUYERS
- 5.13.4 THREAT OF SUBSTITUTES
- 5.13.5 THREAT OF NEW ENTRANTS
- 5.14 KEY CONFERENCES & EVENTS, 2024-2025
- 5.15 KEY STAKEHOLDERS & BUYING CRITERIA
- 5.15.1 KEY STAKEHOLDERS IN BUYING PROCESS OF HIGH-THROUGHPUT SCREENING PRODUCTS & SERVICES: PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
- 5.15.2 BUYING CRITERIA FOR HIGH-THROUGHPUT SCREENING PRODUCTS & SERVICES
- 5.15.3 BUYING CRITERIA FOR HIGH-THROUGHPUT SCREENING PRODUCTS & SERVICES, BY END USER
6 HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY OFFERING
- 6.1 INTRODUCTION
- 6.2 CONSUMABLES
- 6.2.1 REAGENTS & ASSAY KITS
- 6.2.1.1 Growing applications of HTS in drug discovery and life science research to support demand for consumables
- 6.2.2 LABORATORY CONSUMABLES
- 6.2.2.1 Growing automation in high-throughput screening to propel market growth
- 6.2.1 REAGENTS & ASSAY KITS
- 6.3 INSTRUMENTS
- 6.3.1 LIQUID HANDLING SYSTEMS
- 6.3.1.1 Ongoing technological advancements and automation to support market growth
- 6.3.2 DETECTION SYSTEMS
- 6.3.2.1 High demand for high-throughput and sensitive detection systems to propel market
- 6.3.3 IMAGING INSTRUMENTS
- 6.3.3.1 Advancements in high-content imaging systems to boost market
- 6.3.4 OTHER INSTRUMENTS
- 6.3.1 LIQUID HANDLING SYSTEMS
- 6.4 SERVICES
- 6.4.1 INCREASING ASSAY COMPLEXITIES AND GROWING NEED FOR COST-EFFECTIVE AND SPECIALIZED HTS EXPERTISE TO BOOST DEMAND
- 6.5 SOFTWARE
- 6.5.1 ONGOING INTEGRATION OF ARTIFICIAL INTELLIGENCE AND MACHINE LEARNING SOFTWARE TOOLS TO DRIVE MARKET
7 HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY APPLICATION
- 7.1 INTRODUCTION
- 7.2 DRUG DISCOVERY
- 7.2.1 GROWING DEMAND FOR MORE EFFECTIVE METHODS TO IDENTIFY NEW DRUG CANDIDATES TO SUPPORT MARKET GROWTH
- 7.3 BIOCHEMICAL SCREENING
- 7.3.1 GROWING AWARENESS OF GENETIC DISORDERS AND SCREENING TESTS TO BOOST MARKET GROWTH
- 7.4 LIFE SCIENCE RESEARCH
- 7.4.1 INCREASING INVESTMENTS IN STEM CELL RESEARCH TO CONTRIBUTE TO MARKET GROWTH
- 7.5 OTHER APPLICATIONS
8 HIGH-THROUGHPUT SCREENING MARKET, BY TECHNOLOGY
- 8.1 INTRODUCTION
- 8.2 CELL-BASED ASSAYS
- 8.2.1 2D CELL CULTURES
- 8.2.1.1 Cost-effectiveness of 2D cell cultures to promote market growth
- 8.2.2 3D CELL CULTURES
- 8.2.2.1 Scaffold-based technology
- 8.2.2.1.1 Hydrogels
- 8.2.2.1.1.1 Animal-derived hydrogels
- 8.2.2.1.1 Hydrogels
- 8.2.2.1 Scaffold-based technology
- 8.2.1 2D CELL CULTURES
8.2.2.1.1.1.1 Matrigel
8.2.2.1.1.1.1.1 Increasing applications of Matrigel in drug discovery and life science research to support market growth
8.2.2.1.1.1.2 Collagen
8.2.2.1.1.1.2.1 Growing demand for personalized medicines to support market growth
- 8.2.2.1.1.2 Synthetic hydrogels
8.2.2.1.1.2.1 Better consistency and low risk of contamination to increase adoption and drive growth
- 8.2.2.1.1.3 Alginate/Agarose
8.2.2.1.1.3.1 Ability of alginate to enhance accuracy and relevance to propel adoption
- 8.2.2.1.2 Inert matrices/Solid scaffolds
- 8.2.2.1.2.1 Lack of native-like microenvironment and other disadvantages to restrain growth
- 8.2.2.1.3 Micropatterned surfaces
- 8.2.2.1.3.1 Greater enzyme levels and drug reactivity to support adoption
- 8.2.2.2 Scaffold-free technology
- 8.2.2.2.1 Ultra-low-binding plates
- 8.2.2.2.1.1 Demand for high-quality, low-background assays to boost market
- 8.2.2.2.2 Hanging-drop plates
- 8.2.2.2.2.1 Cost-effectiveness to boost adoption among end users
- 8.2.2.2.3 Other scaffold-free technologies
- 8.2.2.2.1 Ultra-low-binding plates
- 8.2.3 REPORTER-BASED ASSAYS
- 8.2.3.1 Growing applications of gene expression to support growth
- 8.2.4 PERFUSION CELL CULTURES
- 8.2.4.1 Ongoing research to develop perfusion cell culture technology for drug discovery to support adoption
- 8.3 LAB-ON-A-CHIP
- 8.3.1 INCREASING APPLICATIONS OF LAB-ON-A-CHIP TECHNOLOGY FOR HTS AND PRECISION MEDICINE DEVELOPMENT TO SUPPORT MARKET GROWTH
- 8.4 LABEL-FREE TECHNOLOGY
- 8.4.1 ABILITY TO CONDUCT LABEL-FREE INVESTIGATION OF BIOMOLECULAR INTERACTIONS TO PROPEL ADOPTION
9 HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY END USER
- 9.1 INTRODUCTION
- 9.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
- 9.2.1 GROWING DEMAND FOR HTS SOLUTIONS IN LEAD DISCOVERY TO SUPPORT MARKET GROWTH
- 9.3 ACADEMIC & RESEARCH INSTITUTES
- 9.3.1 GROWING ADOPTION OF HTS IN COLLABORATIVE ACADEMIC & RESEARCH ACTIVITIES TO AID MARKET GROWTH
- 9.4 CONTRACT RESEARCH ORGANIZATIONS (CROS)
- 9.4.1 INCREASING OUTSOURCING OF R&D ACTIVITIES TO DRIVE MARKET GROWTH FOR CROS
- 9.5 OTHER END USERS
10 HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY REGION
- 10.1 INTRODUCTION
- 10.2 NORTH AMERICA
- 10.2.1 NORTH AMERICA: RECESSION IMPACT
- 10.2.2 US
- 10.2.2.1 Presence of major research institutes and key pharmaceutical companies to support market growth
- 10.2.3 CANADA
- 10.2.3.1 Government initiatives promoting research to support market growth
- 10.3 EUROPE
- 10.3.1 EUROPE: RECESSION IMPACT
- 10.3.2 GERMANY
- 10.3.2.1 Increasing research initiatives to boost market growth
- 10.3.3 UK
- 10.3.3.1 Investments by pharmaceutical sponsors for drug discovery to support market
- 10.3.4 FRANCE
- 10.3.4.1 Large pharmaceutical R&D expenditure to drive market growth
- 10.3.5 ITALY
- 10.3.5.1 Strong collaborative research networks to fuel growth
- 10.3.6 SPAIN
- 10.3.6.1 Rising R&D expenditure and increasing public-private partnerships to boost market
- 10.3.7 REST OF EUROPE
- 10.4 ASIA PACIFIC
- 10.4.1 ASIA PACIFIC: RECESSION IMPACT
- 10.4.2 CHINA
- 10.4.2.1 Growing research and collaborations in field of drug discovery to support growth of market
- 10.4.3 JAPAN
- 10.4.3.1 Growing focus on research and strategic collaborations to support market growth
- 10.4.4 INDIA
- 10.4.4.1 Developing healthcare industry and ongoing government initiatives to create favorable opportunities for market players
- 10.4.5 AUSTRALIA
- 10.4.5.1 Growing pharmaceutical industry to create favorable opportunities for market players
- 10.4.6 SOUTH KOREA
- 10.4.6.1 Growing pharmaceutical industry to favor market growth
- 10.4.7 REST OF ASIA PACIFIC (ROAPAC)
- 10.5 LATIN AMERICA
- 10.5.1 LATIN AMERICA: RECESSION IMPACT
- 10.5.2 BRAZIL
- 10.5.2.1 Gradual growth in research to contribute to growth
- 10.5.3 MEXICO
- 10.5.3.1 Favorable government support to contribute to growth
- 10.5.4 REST OF LATIN AMERICA
- 10.6 MIDDLE EAST
- 10.6.1 MIDDLE EAST: RECESSION IMPACT
- 10.6.2 GCC COUNTRIES
- 10.6.2.1 Saudi Arabia
- 10.6.2.1.1 Growing pharmaceuticals industry to support market growth
- 10.6.2.2 UAE
- 10.6.2.2.1 High R&D expenditure and advanced healthcare infrastructure to boost market growth
- 10.6.2.3 Rest of GCC Countries
- 10.6.2.1 Saudi Arabia
- 10.7 AFRICA
- 10.7.1 INCREASING FUNDING AND PARTNERSHIPS IN RESEARCH SECTOR TO AID MARKET GROWTH
- 10.7.2 AFRICA: RECESSION IMPACT
11 COMPETITIVE LANDSCAPE
- 11.1 OVERVIEW
- 11.2 KEY PLAYER STRATEGY/RIGHT TO WIN
- 11.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN HIGH-THROUGHPUT SCREENING (HTS) MARKET
- 11.3 REVENUE ANALYSIS
- 11.4 MARKET SHARE ANALYSIS
- 11.5 COMPANY EVALUATION QUADRANT: KEY PLAYERS, 2023
- 11.5.1 STARS
- 11.5.2 EMERGING LEADERS
- 11.5.3 PERVASIVE PLAYERS
- 11.5.4 PARTICIPANTS
- 11.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023
- 11.5.5.1 Company footprint
- 11.5.5.2 Offering footprint
- 11.5.5.3 Application footprint
- 11.5.5.4 Region footprint
- 11.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023
- 11.6.1 PROGRESSIVE COMPANIES
- 11.6.2 RESPONSIVE COMPANIES
- 11.6.3 DYNAMIC COMPANIES
- 11.6.4 STARTING BLOCKS
- 11.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023
- 11.7 COMPANY VALUATION & FINANCIAL METRICS
- 11.7.1 FINANCIAL METRICS
- 11.7.2 COMPANY VALUATION
- 11.8 BRAND/PRODUCT COMPARISON
- 11.9 COMPETITIVE SCENARIO
- 11.9.1 PRODUCT LAUNCHES
- 11.9.2 DEALS
- 11.9.3 EXPANSIONS
12 COMPANY PROFILES
- 12.1 KEY PLAYERS
- 12.1.1 THERMO FISHER SCIENTIFIC INC.
- 12.1.1.1 Business overview
- 12.1.1.2 Products & services offered
- 12.1.1.3 Recent developments
- 12.1.1.3.1 Product launches & approvals
- 12.1.1.3.2 Deals
- 12.1.1.3.3 Expansions
- 12.1.1.4 MnM view
- 12.1.1.4.1 Right to win
- 12.1.1.4.2 Strategic choices
- 12.1.1.4.3 Weaknesses & competitive threats
- 12.1.2 AGILENT TECHNOLOGIES, INC.
- 12.1.2.1 Business overview
- 12.1.2.2 Products & services offered
- 12.1.2.3 Recent developments
- 12.1.2.3.1 Product launches & upgrades
- 12.1.2.3.2 Deals
- 12.1.2.4 MnM view
- 12.1.2.4.1 Right to win
- 12.1.2.4.2 Strategic choices
- 12.1.2.4.3 Weaknesses & competitive threats
- 12.1.3 MERCK KGAA
- 12.1.3.1 Business overview
- 12.1.3.2 Products & services offered
- 12.1.3.3 Recent developments
- 12.1.3.3.1 Other developments
- 12.1.3.4 MnM view
- 12.1.3.4.1 Right to win
- 12.1.3.4.2 Strategic choices
- 12.1.3.4.3 Weaknesses & competitive threats
- 12.1.4 DANAHER CORPORATION
- 12.1.4.1 Business overview
- 12.1.4.2 Products & services offered
- 12.1.4.3 Recent developments
- 12.1.4.3.1 Product & service launches
- 12.1.4.3.2 Deals
- 12.1.4.3.3 Expansions
- 12.1.5 REVVITY, INC.
- 12.1.5.1 Business overview
- 12.1.5.2 Products & services offered
- 12.1.5.3 Recent developments
- 12.1.5.3.1 Product launches
- 12.1.5.3.2 Deals
- 12.1.6 TECAN GROUP LTD.
- 12.1.6.1 Business overview
- 12.1.6.2 Products & service offered
- 12.1.6.3 Recent developments
- 12.1.6.3.1 Product launches & upgrades
- 12.1.6.3.2 Deals
- 12.1.7 BIO-RAD LABORATORIES, INC.
- 12.1.7.1 Business overview
- 12.1.7.2 Products & services offered
- 12.1.7.3 Recent developments
- 12.1.7.3.1 Product launches
- 12.1.8 CORNING INCORPORATED
- 12.1.8.1 Business overview
- 12.1.8.2 Products & services offered
- 12.1.8.3 Recent developments
- 12.1.8.3.1 Product launches
- 12.1.9 METTLER-TOLEDO INTERNATIONAL INC.
- 12.1.9.1 Business overview
- 12.1.9.2 Products & services offered
- 12.1.9.3 Recent developments
- 12.1.9.3.1 Product launches
- 12.1.10 LONZA GROUP
- 12.1.10.1 Business overview
- 12.1.10.2 Products & services offered
- 12.1.10.3 Recent developments
- 12.1.10.3.1 Deals
- 12.1.11 WATERS CORPORATION
- 12.1.11.1 Business overview
- 12.1.11.2 Products & services offered
- 12.1.11.3 Recent developments
- 12.1.11.3.1 Product launches
- 12.1.11.3.2 Deals
- 12.1.12 SARTORIUS AG
- 12.1.12.1 Business overview
- 12.1.12.2 Products & services offered
- 12.1.12.3 Recent developments
- 12.1.12.3.1 Product launches
- 12.1.13 EPPENDORF SE
- 12.1.13.1 Business overview
- 12.1.13.2 Products & services offered
- 12.1.13.3 Recent developments
- 12.1.13.3.1 Deals
- 12.1.13.3.2 Expansions
- 12.1.14 PORVAIR PLC
- 12.1.14.1 Business overview
- 12.1.14.2 Products & services offered
- 12.1.15 GREINER AG
- 12.1.15.1 Business overview
- 12.1.15.2 Products & services offered
- 12.1.16 CHARLES RIVER LABORATORIES
- 12.1.16.1 Business overview
- 12.1.16.2 products & services offered
- 12.1.16.3 Recent developments
- 12.1.16.3.1 Deals
- 12.1.17 EUROFINS SCIENTIFIC
- 12.1.17.1 Business overview
- 12.1.17.2 Products & services offered
- 12.1.17.3 Recent developments
- 12.1.17.3.1 Service launches
- 12.1.17.3.2 Deals
- 12.1.17.3.3 Expansions
- 12.1.18 HAMILTON COMPANY
- 12.1.18.1 Business overview
- 12.1.18.2 Products & services offered
- 12.1.18.3 Recent developments
- 12.1.18.3.1 Product launches
- 12.1.18.3.2 Deals
- 12.1.19 AURORA BIOMED INC.
- 12.1.19.1 Business overview
- 12.1.19.2 Products & services offered
- 12.1.20 GILSON INCORPORATED
- 12.1.20.1 Business overview
- 12.1.20.2 Products & services offered
- 12.1.20.3 Recent developments
- 12.1.20.3.1 Product launches
- 12.1.20.3.2 Deals
- 12.1.21 BRAND GMBH + CO KG
- 12.1.21.1 Business overview
- 12.1.21.2 Products & services offered
- 12.1.21.3 Recent developments
- 12.1.21.3.1 Expansions
- 12.1.1 THERMO FISHER SCIENTIFIC INC.
- 12.2 OTHER PLAYERS
- 12.2.1 BMG LABTECH GMBH
- 12.2.2 DIANA BIOTECHNOLOGIES, A.S.
- 12.2.3 CREATIVE BIOLABS
- 12.2.4 HIGHRES BIOSOLUTIONS
- 12.2.5 BIOMAT SRL
- 12.2.6 AXXAM S.P.A.
- 12.2.7 SYGNATURE DISCOVERY LIMITED
- 12.2.8 CROWN BIOSCIENCE
13 APPENDIX
- 13.1 DISCUSSION GUIDE
- 13.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
- 13.3 CUSTOMIZATION OPTIONS
- 13.4 RELATED REPORTS
- 13.5 AUTHOR DETAILS
List of Tables
- TABLE 1 GLOBAL INFLATION RATE PROJECTIONS, 2021–2028 (% GROWTH)
- TABLE 2 HIGH-THROUGHPUT SCREENING MARKET: IMPACT ANALYSIS
- TABLE 3 AVERAGE SELLING PRICE FOR HIGH-THROUGHPUT SCREENING PRODUCTS, 2023
- TABLE 4 AVERAGE SELLING PRICE FOR HIGH-THROUGHPUT SCREENING PRODUCTS, BY REGION
- TABLE 5 INDICATIVE PRICING FOR HIGH-THROUGHPUT SCREENING PRODUCTS, BY REGION, 2021–2023 (USD)
- TABLE 6 HIGH-THROUGHPUT SCREENING MARKET: ROLE OF RAW MATERIAL VENDORS
- TABLE 7 HIGH-THROUGHPUT SCREENING MARKET: ROLE OF PRODUCT & SERVICE PROVIDERS
- TABLE 8 HIGH-THROUGHPUT SCREENING MARKET: ROLE OF END USERS
- TABLE 9 HIGH-THROUGHPUT SCREENING MARKET: ROLE OF REGULATORY AUTHORITIES
- TABLE 10 PATENTS FILED, BY DOCUMENT TYPE, 2012–2023
- TABLE 11 INDICATIVE LIST OF PATENTS IN HIGH-THROUGHPUT SCREENING MARKET
- TABLE 12 IMPORT DATA FOR SPECTROMETERS, BY COUNTRY, 2019–2023 (USD THOUSAND)
- TABLE 13 IMPORT VOLUME DATA FOR SPECTROMETERS, BY COUNTRY, 2019–2023 (UNITS)
- TABLE 14 IMPORT DATA FOR MASS SPECTROMETERS, BY COUNTRY, 2022–2023 (USD THOUSAND)
- TABLE 15 IMPORT VOLUME DATA FOR MASS SPECTROMETERS, BY COUNTRY, 2022–2023 (UNITS)
- TABLE 16 EXPORT DATA FOR SPECTROMETERS, BY COUNTRY, 2019–2023 (USD THOUSAND)
- TABLE 17 EXPORT VOLUME DATA FOR SPECTROMETERS, BY COUNTRY, 2019–2023 (UNITS)
- TABLE 18 EXPORT DATA FOR MASS SPECTROMETERS, BY COUNTRY, 2019–2023 (USD THOUSAND)
- TABLE 19 EXPORT VOLUME DATA FOR MASS SPECTROMETERS, BY COUNTRY, 2019–2023 (UNITS)
- TABLE 20 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
- TABLE 21 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
- TABLE 22 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
- TABLE 23 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
- TABLE 24 MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
- TABLE 25 HIGH-THROUGHPUT SCREENING MARKET: PORTER'S FIVE FORCES ANALYSIS
- TABLE 26 HIGH-THROUGHPUT SCREENING MARKET: LIST OF CONFERENCES & EVENTS
- TABLE 28 HIGH-THROUGHPUT SCREENING (HTS) CONSUMABLES MARKET, BY REGION, 2022–2029 (USD MILLION)
- TABLE 29 NORTH AMERICA: HIGH-THROUGHPUT SCREENING (HTS) CONSUMABLES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
- TABLE 30 EUROPE: HIGH-THROUGHPUT SCREENING (HTS) CONSUMABLES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
- TABLE 31 ASIA PACIFIC: HIGH-THROUGHPUT SCREENING (HTS) CONSUMABLES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
- TABLE 32 LATIN AMERICA: HIGH-THROUGHPUT SCREENING (HTS) CONSUMABLES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
- TABLE 33 MIDDLE EAST: HIGH-THROUGHPUT SCREENING (HTS) CONSUMABLES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
- TABLE 34 GCC COUNTRIES: HIGH-THROUGHPUT SCREENING (HTS) CONSUMABLES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
- TABLE 35 HIGH-THROUGHPUT SCREENING (HTS) CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 36 HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR REAGENTS & ASSAY KITS, BY REGION, 2022–2029 (USD MILLION)
- TABLE 37 NORTH AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR REAGENTS & ASSAY KITS, BY COUNTRY, 2022–2029 (USD MILLION)
- TABLE 38 EUROPE: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR REAGENTS & ASSAY KITS, BY COUNTRY, 2022–2029 (USD MILLION)
- TABLE 39 ASIA PACIFIC: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR REAGENTS & ASSAY KITS, BY COUNTRY, 2022–2029 (USD MILLION)
- TABLE 40 LATIN AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR REAGENTS & ASSAY KITS, BY COUNTRY, 2022–2029 (USD MILLION)
- TABLE 41 MIDDLE EAST: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR REAGENTS & ASSAY KITS, BY COUNTRY, 2022–2029 (USD MILLION)
- TABLE 42 GCC COUNTRIES: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR REAGENTS & ASSAY KITS, BY COUNTRY, 2022–2029 (USD MILLION)
- TABLE 43 HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR LABORATORY CONSUMABLES, BY REGION, 2022–2029 (USD MILLION)
- TABLE 44 NORTH AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR LABORATORY CONSUMABLES, BY COUNTRY, 2022–2029 (USD MILLION)
- TABLE 45 EUROPE: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR LABORATORY CONSUMABLES, BY COUNTRY, 2022–2029 (USD MILLION)
- TABLE 46 ASIA PACIFIC: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR LABORATORY CONSUMABLES, BY COUNTRY, 2022–2029 (USD MILLION)
- TABLE 47 LATIN AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR LABORATORY CONSUMABLES, BY COUNTRY, 2022–2029 (USD MILLION)
- TABLE 48 MIDDLE EAST: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR LABORATORY CONSUMABLES, BY COUNTRY, 2022–2029 (USD MILLION)
- TABLE 49 GCC COUNTRIES: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR LABORATORY CONSUMABLES, BY COUNTRY, 2022–2029 (USD MILLION)
- TABLE 50 HIGH-THROUGHPUT SCREENING (HTS) INSTRUMENTS MARKET, BY REGION, 2022–2029 (USD MILLION)
- TABLE 51 NORTH AMERICA: HIGH-THROUGHPUT SCREENING (HTS) INSTRUMENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
- TABLE 52 EUROPE: HIGH-THROUGHPUT SCREENING (HTS) INSTRUMENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
- TABLE 53 ASIA PACIFIC: HIGH-THROUGHPUT SCREENING (HTS) INSTRUMENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
- TABLE 54 LATIN AMERICA: HIGH-THROUGHPUT SCREENING (HTS) INSTRUMENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
- TABLE 55 MIDDLE EAST: HIGH-THROUGHPUT SCREENING (HTS) INSTRUMENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
- TABLE 56 GCC COUNTRIES: HIGH-THROUGHPUT SCREENING (HTS) INSTRUMENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
- TABLE 57 HIGH-THROUGHPUT SCREENING (HTS) INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 58 HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR LIQUID HANDLING SYSTEMS, BY REGION, 2022–2029 (USD MILLION)
- TABLE 59 NORTH AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR LIQUID HANDLING SYSTEMS, BY COUNTRY, 2022–2029 (USD MILLION)
- TABLE 60 EUROPE: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR LIQUID HANDLING SYSTEMS, BY COUNTRY, 2022–2029 (USD MILLION)
- TABLE 61 ASIA PACIFIC: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR LIQUID HANDLING SYSTEMS, BY COUNTRY, 2022–2029 (USD MILLION)
- TABLE 62 LATIN AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR LIQUID HANDLING SYSTEMS, BY COUNTRY, 2022–2029 (USD MILLION)
- TABLE 63 MIDDLE EAST: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR LIQUID HANDLING SYSTEMS, BY COUNTRY, 2022–2029 (USD MILLION)
- TABLE 64 GCC COUNTRIES: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR LIQUID HANDLING SYSTEMS, BY COUNTRY, 2022–2029 (USD MILLION)
- TABLE 65 HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR DETECTION SYSTEMS, BY REGION, 2022–2029 (USD MILLION)
- TABLE 66 NORTH AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR DETECTION SYSTEMS, BY COUNTRY, 2022–2029 (USD MILLION)
- TABLE 67 EUROPE: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR DETECTION SYSTEMS, BY COUNTRY, 2022–2029 (USD MILLION)
- TABLE 68 ASIA PACIFIC: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR DETECTION SYSTEMS, BY COUNTRY, 2022–2029 (USD MILLION)
- TABLE 69 LATIN AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR DETECTION SYSTEMS, BY COUNTRY, 2022–2029 (USD MILLION)
- TABLE 70 MIDDLE EAST: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR DETECTION SYSTEMS, BY COUNTRY, 2022–2029 (USD MILLION)
- TABLE 71 GCC COUNTRIES: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR DETECTION SYSTEMS, BY COUNTRY, 2022–2029 (USD MILLION)
- TABLE 72 HIGH-THROUGHPUT SCREENING MARKET FOR FLOW CYTOMETRY INSTRUMENTS FOR DRUG DISCOVERY APPLICATIONS, BY TYPE, 2022–2029 (UNITS)
- TABLE 73 HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR IMAGING INSTRUMENTS, BY REGION, 2022–2029 (USD MILLION)
- TABLE 74 NORTH AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR IMAGING INSTRUMENTS, BY COUNTRY, 2022–2029 (USD MILLION)
- TABLE 75 EUROPE: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR IMAGING INSTRUMENTS, BY COUNTRY, 2022–2029 (USD MILLION)
- TABLE 76 ASIA PACIFIC: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR IMAGING INSTRUMENTS, BY COUNTRY, 2022–2029 (USD MILLION)
- TABLE 77 LATIN AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR IMAGING INSTRUMENTS, BY COUNTRY, 2022–2029 (USD MILLION)
- TABLE 78 MIDDLE EAST: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR IMAGING INSTRUMENTS, BY COUNTRY, 2022–2029 (USD MILLION)
- TABLE 79 GCC COUNTRIES: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR IMAGING INSTRUMENTS, BY COUNTRY, 2022–2029 (USD MILLION)
- TABLE 80 HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR OTHER INSTRUMENTS, BY REGION, 2022–2029 (USD MILLION)
- TABLE 81 NORTH AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR OTHER INSTRUMENTS, BY COUNTRY, 2022–2029 (USD MILLION)
- TABLE 82 EUROPE: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR OTHER INSTRUMENTS, BY COUNTRY, 2022–2029 (USD MILLION)
- TABLE 83 ASIA PACIFIC: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR OTHER INSTRUMENTS, BY COUNTRY, 2022–2029 (USD MILLION)
- TABLE 84 LATIN AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR OTHER INSTRUMENTS, BY COUNTRY, 2022–2029 (USD MILLION)
- TABLE 85 MIDDLE EAST: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR OTHER INSTRUMENTS, BY COUNTRY, 2022–2029 (USD MILLION)
- TABLE 86 GCC COUNTRIES: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR OTHER INSTRUMENTS, BY COUNTRY, 2022–2029 (USD MILLION)
- TABLE 87 HIGH-THROUGHPUT SCREENING (HTS) SERVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
- TABLE 88 NORTH AMERICA: HIGH-THROUGHPUT SCREENING (HTS) SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
- TABLE 89 EUROPE: HIGH-THROUGHPUT SCREENING (HTS) SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
- TABLE 90 ASIA PACIFIC: HIGH-THROUGHPUT SCREENING (HTS) SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
- TABLE 91 LATIN AMERICA: HIGH-THROUGHPUT SCREENING (HTS) SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
- TABLE 92 MIDDLE EAST: HIGH-THROUGHPUT SCREENING (HTS) SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
- TABLE 93 GCC COUNTRIES: HIGH-THROUGHPUT SCREENING (HTS) SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
- TABLE 94 HIGH-THROUGHPUT SCREENING (HTS) SOFTWARE MARKET, BY REGION, 2022–2029 (USD MILLION)
- TABLE 95 NORTH AMERICA: HIGH-THROUGHPUT SCREENING (HTS) SOFTWARE MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
- TABLE 96 EUROPE: HIGH-THROUGHPUT SCREENING (HTS) SOFTWARE MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
- TABLE 97 ASIA PACIFIC: HIGH-THROUGHPUT SCREENING (HTS) SOFTWARE MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
- TABLE 98 LATIN AMERICA: HIGH-THROUGHPUT SCREENING (HTS) SOFTWARE MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
- TABLE 99 MIDDLE EAST: HIGH-THROUGHPUT SCREENING (HTS) SOFTWARE MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
- TABLE 100 GCC COUNTRIES: HIGH-THROUGHPUT SCREENING (HTS) SOFTWARE MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
- TABLE 101 HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
- TABLE 102 HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR DRUG DISCOVERY APPLICATIONS, BY REGION, 2022–2029 (USD MILLION)
- TABLE 103 NORTH AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR DRUG DISCOVERY APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
- TABLE 104 EUROPE: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR DRUG DISCOVERY APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
- TABLE 105 ASIA PACIFIC: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR DRUG DISCOVERY APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
- TABLE 106 LATIN AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR DRUG DISCOVERY APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
- TABLE 107 MIDDLE EAST: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR DRUG DISCOVERY APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
- TABLE 108 GCC COUNTRIES: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR DRUG DISCOVERY APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
- TABLE 109 HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR BIOCHEMICAL SCREENING APPLICATIONS, BY REGION, 2022–2029 (USD MILLION)
- TABLE 110 NORTH AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR BIOCHEMICAL SCREENING APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
- TABLE 111 EUROPE: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR BIOCHEMICAL SCREENING APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
- TABLE 112 ASIA PACIFIC: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR BIOCHEMICAL SCREENING APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
- TABLE 113 LATIN AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR BIOCHEMICAL SCREENING APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
- TABLE 114 MIDDLE EAST: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR BIOCHEMICAL SCREENING APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
- TABLE 115 GCC COUNTRIES: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR BIOCHEMICAL SCREENING APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
- TABLE 116 HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR LIFE SCIENCE RESEARCH APPLICATIONS, BY REGION, 2022–2029 (USD MILLION)
- TABLE 117 NORTH AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR LIFE SCIENCE RESEARCH APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
- TABLE 118 EUROPE: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR LIFE SCIENCE RESEARCH APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
- TABLE 119 ASIA PACIFIC: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR LIFE SCIENCE RESEARCH APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
- TABLE 120 LATIN AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR LIFE SCIENCE RESEARCH APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
- TABLE 121 MIDDLE EAST: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR LIFE SCIENCE RESEARCH APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
- TABLE 122 GCC COUNTRIES: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR LIFE SCIENCE RESEARCH APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
- TABLE 123 HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR OTHER APPLICATIONS, BY REGION, 2022–2029 (USD MILLION)
- TABLE 124 NORTH AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
- TABLE 125 EUROPE: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
- TABLE 126 ASIA PACIFIC: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
- TABLE 127 LATIN AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
- TABLE 128 MIDDLE EAST: HIGH-THROUGHPUT SCREENING (HTS) MARKET OTHER APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
- TABLE 129 GCC COUNTRIES: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
- TABLE 130 HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
- TABLE 131 COMPARISON OF 2D AND 3D CELL CULTURES
- TABLE 132 HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR CELL-BASED ASSAYS, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 133 HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR CELL-BASED ASSAYS, BY REGION, 2022–2029 (USD MILLION)
- TABLE 134 NORTH AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR CELL-BASED ASSAYS, BY COUNTRY, 2022–2029 (USD MILLION)
- TABLE 135 EUROPE: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR CELL-BASED ASSAYS, BY COUNTRY, 2022–2029 (USD MILLION)
- TABLE 136 ASIA PACIFIC: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR CELL-BASED ASSAYS, BY COUNTRY, 2022–2029 (USD MILLION)
- TABLE 137 LATIN AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR CELL-BASED ASSAYS, BY COUNTRY, 2022–2029 (USD MILLION)
- TABLE 138 MIDDLE EAST: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR CELL-BASED ASSAYS, BY COUNTRY, 2022–2029 (USD MILLION)
- TABLE 139 GCC COUNTRIES: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR CELL-BASED ASSAYS, BY COUNTRY, 2022–2029 (USD MILLION)
- TABLE 140 HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR 2D CELL CULTURES, BY REGION, 2022–2029 (USD MILLION)
- TABLE 141 NORTH AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR 2D CELL CULTURES, BY COUNTRY, 2022–2029 (USD MILLION)
- TABLE 142 EUROPE: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR 2D CELL CULTURES, BY COUNTRY, 2022–2029 (USD MILLION)
- TABLE 143 ASIA PACIFIC: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR 2D CELL CULTURES, BY COUNTRY, 2022–2029 (USD MILLION)
- TABLE 144 LATIN AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR 2D CELL CULTURES, BY COUNTRY, 2022–2029 (USD MILLION)
- TABLE 145 MIDDLE EAST: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR 2D CELL CULTURES, BY COUNTRY, 2022–2029 (USD MILLION)
- TABLE 146 GCC COUNTRIES: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR 2D CELL CULTURES, BY COUNTRY, 2022–2029 (USD MILLION)
- TABLE 147 HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR 3D CELL CULTURES, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 148 HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR 3D CELL CULTURES, BY REGION, 2022–2029 (USD MILLION)
- TABLE 149 NORTH AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR 3D CELL CULTURES, BY COUNTRY, 2022–2029 (USD MILLION)
- TABLE 150 EUROPE: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR 3D CELL CULTURES, BY COUNTRY, 2022–2029 (USD MILLION)
- TABLE 151 ASIA PACIFIC: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR 3D CELL CULTURES, BY COUNTRY, 2022–2029 (USD MILLION)
- TABLE 152 LATIN AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR 3D CELL CULTURES, BY COUNTRY, 2022–2029 (USD MILLION)
- TABLE 153 MIDDLE EAST: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR 3D CELL CULTURES, BY COUNTRY, 2022–2029 (USD MILLION)
- TABLE 154 GCC COUNTRIES: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR 3D CELL CULTURES, BY COUNTRY, 2022–2029 (USD MILLION)
- TABLE 155 HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SCAFFOLD-BASED TECHNOLOGY, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 156 HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SCAFFOLD-BASED TECHNOLOGY, BY REGION, 2022–2029 (USD MILLION)
- TABLE 157 NORTH AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SCAFFOLD-BASED TECHNOLOGY, BY COUNTRY, 2022–2029 (USD MILLION)
- TABLE 158 EUROPE: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SCAFFOLD-BASED TECHNOLOGY, BY COUNTRY, 2022–2029 (USD MILLION)
- TABLE 159 ASIA PACIFIC: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SCAFFOLD-BASED TECHNOLOGY, BY COUNTRY, 2022–2029 (USD MILLION)
- TABLE 160 LATIN AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SCAFFOLD-BASED TECHNOLOGY, BY COUNTRY, 2022–2029 (USD MILLION)
- TABLE 161 MIDDLE EAST: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SCAFFOLD-BASED TECHNOLOGY, BY COUNTRY, 2022–2029 (USD MILLION)
- TABLE 162 GCC COUNTRIES: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SCAFFOLD-BASED TECHNOLOGY, BY COUNTRY, 2022–2029 (USD MILLION)
- TABLE 163 HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR HYDROGELS, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 164 HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR HYDROGELS, BY REGION, 2022–2029 (USD MILLION)
- TABLE 165 NORTH AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR HYDROGELS, BY COUNTRY, 2022–2029 (USD MILLION)
- TABLE 166 EUROPE: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR HYDROGELS, BY COUNTRY, 2022–2029 (USD MILLION)
- TABLE 167 ASIA PACIFIC: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR HYDROGELS, BY COUNTRY, 2022–2029 (USD MILLION)
- TABLE 168 LATIN AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR HYDROGELS, BY COUNTRY, 2022–2029 (USD MILLION)
- TABLE 169 MIDDLE EAST: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR HYDROGELS, BY COUNTRY, 2022–2029 (USD MILLION)
- TABLE 170 GCC COUNTRIES: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR HYDROGELS, BY COUNTRY, 2022–2029 (USD MILLION)
- TABLE 171 HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR ANIMAL-DERIVED HYDROGELS, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 172 HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR ANIMAL-DERIVED HYDROGELS, BY REGION, 2022–2029 (USD MILLION)
- TABLE 173 NORTH AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR ANIMAL-DERIVED HYDROGELS, BY COUNTRY, 2022–2029 (USD MILLION)
- TABLE 174 EUROPE: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR ANIMAL-DERIVED HYDROGELS, BY COUNTRY, 2022–2029 (USD MILLION)
- TABLE 175 ASIA PACIFIC: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR ANIMAL-DERIVED HYDROGELS, BY COUNTRY, 2022–2029 (USD MILLION)
- TABLE 176 LATIN AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR ANIMAL-DERIVED HYDROGELS, BY COUNTRY, 2022–2029 (USD MILLION)
- TABLE 177 MIDDLE EAST: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR ANIMAL-DERIVED HYDROGELS, BY COUNTRY, 2022–2029 (USD MILLION)
- TABLE 178 GCC COUNTRIES: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR ANIMAL-DERIVED HYDROGELS, BY COUNTRY, 2022–2029 (USD MILLION)
- TABLE 179 HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR MATRIGEL, BY REGION, 2022–2029 (USD MILLION)
- TABLE 180 NORTH AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR MATRIGEL, BY COUNTRY, 2022–2029 (USD MILLION)
- TABLE 181 EUROPE: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR MATRIGEL, BY COUNTRY, 2022–2029 (USD MILLION)
- TABLE 182 ASIA PACIFIC: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR MATRIGEL, BY COUNTRY, 2022–2029 (USD MILLION)
- TABLE 183 LATIN AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR MATRIGEL, BY COUNTRY, 2022–2029 (USD MILLION)
- TABLE 184 MIDDLE EAST: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR MATRIGEL, BY COUNTRY, 2022–2029 (USD MILLION)
- TABLE 185 GCC COUNTRIES: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR MATRIGEL, BY COUNTRY, 2022–2029 (USD MILLION)
- TABLE 186 HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR COLLAGEN, BY REGION, 2022–2029 (USD MILLION)
- TABLE 187 NORTH AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR COLLAGEN, BY COUNTRY, 2022–2029 (USD MILLION)
- TABLE 188 EUROPE: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR COLLAGEN, BY COUNTRY, 2022–2029 (USD MILLION)
- TABLE 189 ASIA PACIFIC: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR COLLAGEN, BY COUNTRY, 2022–2029 (USD MILLION)
- TABLE 190 LATIN AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR COLLAGEN, BY COUNTRY, 2022–2029 (USD MILLION)
- TABLE 191 MIDDLE EAST: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR COLLAGEN, BY COUNTRY, 2022–2029 (USD MILLION)
- TABLE 192 GCC COUNTRIES: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR COLLAGEN, BY COUNTRY, 2022–2029 (USD MILLION)
- TABLE 193 HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SYNTHETIC HYDROGELS, BY REGION, 2022–2029 (USD MILLION)
- TABLE 194 NORTH AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SYNTHETIC HYDROGELS, BY COUNTRY, 2022–2029 (USD MILLION)
- TABLE 195 EUROPE: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SYNTHETIC HYDROGELS, BY COUNTRY, 2022–2029 (USD MILLION)
- TABLE 196 ASIA PACIFIC: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SYNTHETIC HYDROGELS, BY COUNTRY, 2022–2029 (USD MILLION)
- TABLE 197 LATIN AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SYNTHETIC HYDROGELS, BY COUNTRY, 2022–2029 (USD MILLION)
- TABLE 198 MIDDLE EAST: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SYNTHETIC HYDROGELS, BY COUNTRY, 2022–2029 (USD MILLION)
- TABLE 199 GCC COUNTRIES: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SYNTHETIC HYDROGELS, BY COUNTRY, 2022–2029 (USD MILLION)
- TABLE 200 HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR ALGINATE/AGAROSE, BY REGION, 2022–2029 (USD MILLION)
- TABLE 201 NORTH AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR ALGINATE/AGAROSE, BY COUNTRY, 2022–2029 (USD MILLION)
- TABLE 202 EUROPE: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR ALGINATE/AGAROSE, BY COUNTRY, 2022–2029 (USD MILLION)
- TABLE 203 ASIA PACIFIC: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR ALGINATE/AGAROSE, BY COUNTRY, 2022–2029 (USD MILLION)
- TABLE 204 LATIN AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR ALGINATE/AGAROSE, BY COUNTRY, 2022–2029 (USD MILLION)
- TABLE 205 MIDDLE EAST: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR ALGINATE/AGAROSE, BY COUNTRY, 2022–2029 (USD MILLION)
- TABLE 206 GCC COUNTRIES: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR ALGINATE/AGAROSE, BY COUNTRY, 2022–2029 (USD MILLION)
- TABLE 207 HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR INERT MATRICES/SOLID SCAFFOLDS, BY REGION, 2022–2029 (USD MILLION)
- TABLE 208 NORTH AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR INERT MATRICES/SOLID SCAFFOLDS, BY COUNTRY, 2022–2029 (USD MILLION)
- TABLE 209 EUROPE: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR INERT MATRICES/SOLID SCAFFOLDS, BY COUNTRY, 2022–2029 (USD MILLION)
- TABLE 210 ASIA PACIFIC: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR INERT MATRICES/SOLID SCAFFOLDS, BY COUNTRY, 2022–2029 (USD MILLION)
- TABLE 211 LATIN AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR INERT MATRICES/SOLID SCAFFOLDS, BY COUNTRY, 2022–2029 (USD MILLION)
- TABLE 212 MIDDLE EAST: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR INERT MATRICES/SOLID SCAFFOLDS, BY COUNTRY, 2022–2029 (USD MILLION)
- TABLE 213 GCC COUNTRIES: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR INERT MATRICES/SOLID SCAFFOLDS, BY COUNTRY, 2022–2029 (USD MILLION)
- TABLE 214 HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR MICROPATTERNED SURFACES, BY REGION, 2022–2029 (USD MILLION)
- TABLE 215 NORTH AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR MICROPATTERNED SURFACES, BY COUNTRY, 2022–2029 (USD MILLION)
- TABLE 216 EUROPE: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR MICROPATTERNED SURFACES, BY COUNTRY, 2022–2029 (USD MILLION)
- TABLE 217 ASIA PACIFIC: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR MICROPATTERNED SURFACES, BY COUNTRY, 2022–2029 (USD MILLION)
- TABLE 218 LATIN AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR MICROPATTERNED SURFACES, BY COUNTRY, 2022–2029 (USD MILLION)
- TABLE 219 MIDDLE EAST: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR MICROPATTERNED SURFACES, BY COUNTRY, 2022–2029 (USD MILLION)
- TABLE 220 GCC COUNTRIES: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR MICROPATTERNED SURFACES, BY COUNTRY, 2022–2029 (USD MILLION)
- TABLE 221 HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SCAFFOLD-FREE TECHNOLOGY, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 222 HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SCAFFOLD-FREE TECHNOLOGY, BY REGION, 2022–2029 (USD MILLION)
- TABLE 223 NORTH AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SCAFFOLD-FREE TECHNOLOGY, BY COUNTRY, 2022–2029 (USD MILLION)
- TABLE 224 EUROPE: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SCAFFOLD-FREE TECHNOLOGY, BY COUNTRY, 2022–2029 (USD MILLION)
- TABLE 225 ASIA PACIFIC: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SCAFFOLD-FREE TECHNOLOGY, BY COUNTRY, 2022–2029 (USD MILLION)
- TABLE 226 LATIN AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SCAFFOLD-FREE TECHNOLOGY, BY COUNTRY, 2022–2029 (USD MILLION)
- TABLE 227 MIDDLE EAST: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SCAFFOLD-FREE TECHNOLOGY, BY COUNTRY, 2022–2029 (USD MILLION)
- TABLE 228 GCC COUNTRIES: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SCAFFOLD-FREE TECHNOLOGY, BY COUNTRY, 2022–2029 (USD MILLION)
- TABLE 229 HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR ULTRA-LOW-BINDING PLATES, BY REGION, 2022–2029 (USD MILLION)
- TABLE 230 NORTH AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR ULTRA-LOW-BINDING PLATES, BY COUNTRY, 2022–2029 (USD MILLION)
- TABLE 231 EUROPE: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR ULTRA-LOW-BINDING PLATES, BY COUNTRY, 2022–2029 (USD MILLION)
- TABLE 232 ASIA PACIFIC: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR ULTRA-LOW-BINDING PLATES, BY COUNTRY, 2022–2029 (USD MILLION)
- TABLE 233 LATIN AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR ULTRA-LOW-BINDING PLATES, BY COUNTRY, 2022–2029 (USD MILLION)
- TABLE 234 MIDDLE EAST: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR ULTRA-LOW-BINDING PLATES, BY COUNTRY, 2022–2029 (USD MILLION)
- TABLE 235 GCC COUNTRIES: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR ULTRA-LOW-BINDING PLATES, BY COUNTRY, 2022–2029 (USD MILLION)
- TABLE 236 HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR HANGING-DROP PLATES, BY REGION, 2022–2029 (USD MILLION)
- TABLE 237 NORTH AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR HANGING-DROP PLATES, BY COUNTRY, 2022–2029 (USD MILLION)
- TABLE 238 EUROPE: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR HANGING-DROP PLATES, BY COUNTRY, 2022–2029 (USD MILLION)
- TABLE 239 ASIA PACIFIC: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR HANGING-DROP PLATES, BY COUNTRY, 2022–2029 (USD MILLION)
- TABLE 240 LATIN AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR HANGING-DROP PLATES, BY COUNTRY, 2022–2029 (USD MILLION)
- TABLE 241 MIDDLE EAST: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR HANGING-DROP PLATES, BY COUNTRY, 2022–2029 (USD MILLION)
- TABLE 242 GCC COUNTRIES: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR HANGING-DROP PLATES, BY COUNTRY, 2022–2029 (USD MILLION)
- TABLE 243 HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR OTHER SCAFFOLD-FREE TECHNOLOGIES, BY REGION, 2022–2029 (USD MILLION)
- TABLE 244 NORTH AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR OTHER SCAFFOLD-FREE TECHNOLOGIES, BY COUNTRY, 2022–2029 (USD MILLION)
- TABLE 245 EUROPE: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR OTHER SCAFFOLD-FREE TECHNOLOGIES, BY COUNTRY, 2022–2029 (USD MILLION)
- TABLE 246 ASIA PACIFIC: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR OTHER SCAFFOLD-FREE TECHNOLOGIES, BY COUNTRY, 2022–2029 (USD MILLION)
- TABLE 247 LATIN AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR OTHER SCAFFOLD-FREE TECHNOLOGIES, BY COUNTRY, 2022–2029 (USD MILLION)
- TABLE 248 MIDDLE EAST: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR OTHER SCAFFOLD-FREE TECHNOLOGIES, BY COUNTRY, 2022–2029 (USD MILLION)
- TABLE 249 GCC COUNTRIES: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR OTHER SCAFFOLD-FREE TECHNOLOGIES, BY COUNTRY, 2022–2029 (USD MILLION)
- TABLE 250 HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR REPORTER-BASED ASSAYS, BY REGION, 2022–2029 (USD MILLION)
- TABLE 251 NORTH AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR REPORTER-BASED ASSAYS, BY COUNTRY, 2022–2029 (USD MILLION)
- TABLE 252 EUROPE: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR REPORTER-BASED ASSAYS, BY COUNTRY, 2022–2029 (USD MILLION)
- TABLE 253 ASIA PACIFIC: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR REPORTER-BASED ASSAYS, BY COUNTRY, 2022–2029 (USD MILLION)
- TABLE 254 LATIN AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR REPORTER-BASED ASSAYS, BY COUNTRY, 2022–2029 (USD MILLION)
- TABLE 255 MIDDLE EAST: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR REPORTER-BASED ASSAYS, BY COUNTRY, 2022–2029 (USD MILLION)
- TABLE 256 GCC COUNTRIES: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR REPORTER-BASED ASSAYS, BY COUNTRY, 2022–2029 (USD MILLION)
- TABLE 257 HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR PERFUSION CELL CULTURES, BY REGION, 2022–2029 (USD MILLION)
- TABLE 258 NORTH AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR PERFUSION CELL CULTURES, BY COUNTRY, 2022–2029 (USD MILLION)
- TABLE 259 EUROPE: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR PERFUSION CELL CULTURES, BY COUNTRY, 2022–2029 (USD MILLION)
- TABLE 260 ASIA PACIFIC: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR PERFUSION CELL CULTURES, BY COUNTRY, 2022–2029 (USD MILLION)
- TABLE 261 LATIN AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR PERFUSION CELL CULTURES, BY COUNTRY, 2022–2029 (USD MILLION)
- TABLE 262 MIDDLE EAST: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR PERFUSION CELL CULTURES, BY COUNTRY, 2022–2029 (USD MILLION)
- TABLE 263 GCC COUNTRIES: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR PERFUSION CELL CULTURES, BY COUNTRY, 2022–2029 (USD MILLION)
- TABLE 264 HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR LAB-ON-A-CHIP TECHNOLOGY, BY REGION, 2022–2029 (USD MILLION)
- TABLE 265 NORTH AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR LAB-ON-A-CHIP TECHNOLOGY, BY COUNTRY, 2022–2029 (USD MILLION)
- TABLE 266 EUROPE: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR LAB-ON-A-CHIP TECHNOLOGY, BY COUNTRY, 2022–2029 (USD MILLION)
- TABLE 267 ASIA PACIFIC: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR LAB-ON-A-CHIP TECHNOLOGY, BY COUNTRY, 2022–2029 (USD MILLION)
- TABLE 268 LATIN AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR LAB-ON-A-CHIP TECHNOLOGY, BY COUNTRY, 2022–2029 (USD MILLION)
- TABLE 269 MIDDLE EAST: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR LAB-ON-A-CHIP TECHNOLOGY, BY COUNTRY, 2022–2029 (USD MILLION)
- TABLE 270 GCC COUNTRIES: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR LAB-ON-A-CHIP TECHNOLOGY, BY COUNTRY, 2022–2029 (USD MILLION)
- TABLE 271 HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR LABEL-FREE TECHNOLOGY, BY REGION, 2022–2029 (USD MILLION)
- TABLE 272 NORTH AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR LABEL-FREE TECHNOLOGY, BY COUNTRY, 2022–2029 (USD MILLION)
- TABLE 273 EUROPE: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR LABEL-FREE TECHNOLOGY, BY COUNTRY, 2022–2029 (USD MILLION)
- TABLE 274 ASIA PACIFIC: HIGH-THROUGHPUT SCREENING (HTS) MARKET LABEL-FREE TECHNOLOGY, BY COUNTRY, 2022–2029 (USD MILLION)
- TABLE 275 LATIN AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR LABEL-FREE TECHNOLOGY, BY COUNTRY, 2022–2029 (USD MILLION)
- TABLE 276 MIDDLE EAST: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR LABEL-FREE TECHNOLOGY, BY COUNTRY, 2022–2029 (USD MILLION)
- TABLE 277 GCC COUNTRIES: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR LABEL-FREE TECHNOLOGY, BY COUNTRY, 2022–2029 (USD MILLION)
- TABLE 278 HIGH-THROUGHPUT SCREENING MARKET (HTS), BY END USER, 2022–2029 (USD MILLION)
- TABLE 279 HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2022–2029 (USD MILLION)
- TABLE 280 NORTH AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION)
- TABLE 281 EUROPE: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION)
- TABLE 282 ASIA PACIFIC: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION)
- TABLE 283 LATIN AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION)
- TABLE 284 MIDDLE EAST: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION)
- TABLE 285 GCC COUNTRIES: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION)
- TABLE 286 HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2022–2029 (USD MILLION)
- TABLE 287 NORTH AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION)
- TABLE 288 EUROPE: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION)
- TABLE 289 ASIA PACIFIC: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION)
- TABLE 290 LATIN AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION)
- TABLE 291 MIDDLE EAST: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION)
- TABLE 292 GCC COUNTRIES: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION)
- TABLE 293 HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2022–2029 (USD MILLION)
- TABLE 294 NORTH AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
- TABLE 295 EUROPE: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
- TABLE 296 ASIA PACIFIC: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
- TABLE 297 LATIN AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
- TABLE 298 MIDDLE EAST: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
- TABLE 299 GCC COUNTRIES: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
- TABLE 300 HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR OTHER END USERS, BY REGION, 2022–2029 (USD MILLION)
- TABLE 301 NORTH AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR OTHER END USERS, BY COUNTRY, 2022–2029 (USD MILLION)
- TABLE 302 EUROPE: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR OTHER END USERS, BY COUNTRY, 2022–2029 (USD MILLION)
- TABLE 303 ASIA PACIFIC: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR OTHER END USERS, BY COUNTRY, 2022–2029 (USD MILLION)
- TABLE 304 LATIN AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR OTHER END USERS, BY COUNTRY, 2022–2029 (USD MILLION)
- TABLE 305 MIDDLE EAST: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR OTHER END USERS, BY COUNTRY, 2022–2029 (USD MILLION)
- TABLE 306 GCC COUNTRIES: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR OTHER END USERS, BY COUNTRY, 2022–2029 (USD MILLION)
- TABLE 307 HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY REGION, 2022–2029 (USD MILLION)
- TABLE 308 NORTH AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
- TABLE 309 NORTH AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY OFFERING, 2022–2029 (USD MILLION)
- TABLE 310 NORTH AMERICA: HIGH-THROUGHPUT SCREENING (HTS) CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 311 NORTH AMERICA: HIGH-THROUGHPUT SCREENING (HTS) INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 312 NORTH AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
- TABLE 313 NORTH AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR CELL-BASED ASSAYS, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 314 NORTH AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR 3D CELL CULTURES, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 315 NORTH AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SCAFFOLD-BASED TECHNOLOGY, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 316 NORTH AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR HYDROGELS, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 317 NORTH AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR ANIMAL-DERIVED HYDROGELS, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 318 NORTH AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SCAFFOLD-FREE TECHNOLOGY, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 319 NORTH AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
- TABLE 320 NORTH AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY END USER, 2022–2029 (USD MILLION)
- TABLE 321 US: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY OFFERING, 2022–2029 (USD MILLION)
- TABLE 322 US: HIGH-THROUGHPUT SCREENING (HTS) CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 323 US: HIGH-THROUGHPUT SCREENING (HTS) INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 324 US: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
- TABLE 325 US: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR CELL-BASED ASSAYS, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 326 US: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR 3D CELL CULTURES, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 327 US: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SCAFFOLD-BASED TECHNOLOGY, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 328 US: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR HYDROGELS, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 329 US: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR ANIMAL-DERIVED HYDROGELS, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 330 US: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SCAFFOLD-FREE TECHNOLOGY, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 331 US: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
- TABLE 332 US: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY END USER, 2022–2029 (USD MILLION)
- TABLE 333 CANADA: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY OFFERING, 2022–2029 (USD MILLION)
- TABLE 334 CANADA: HIGH-THROUGHPUT SCREENING (HTS) CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 335 CANADA: HIGH-THROUGHPUT SCREENING (HTS) INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 336 CANADA: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
- TABLE 337 CANADA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR CELL-BASED ASSAYS, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 338 CANADA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR 3D CELL CULTURES, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 339 CANADA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SCAFFOLD-BASED TECHNOLOGY, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 340 CANADA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR HYDROGELS,BY TYPE, 2022–2029 (USD MILLION)
- TABLE 341 CANADA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR ANIMAL-DERIVED HYDROGELS, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 342 CANADA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SCAFFOLD-FREE TECHNOLOGY, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 343 CANADA: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
- TABLE 344 CANADA: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY END USER, 2022–2029 (USD MILLION)
- TABLE 345 EUROPE: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
- TABLE 346 EUROPE: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY OFFERING, 2022–2029 (USD MILLION)
- TABLE 347 EUROPE: HIGH-THROUGHPUT SCREENING (HTS) CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 348 EUROPE: HIGH-THROUGHPUT SCREENING (HTS) INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 349 EUROPE: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
- TABLE 350 EUROPE: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR CELL-BASED ASSAYS, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 351 EUROPE HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR 3D CELL CULTURES, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 352 EUROPE: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SCAFFOLD-BASED TECHNOLOGY, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 353 EUROPE: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR HYDROGELS, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 354 EUROPE: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR ANIMAL-DERIVED HYDROGELS, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 355 EUROPE: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SCAFFOLD-FREE TECHNOLOGY, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 356 EUROPE: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
- TABLE 357 EUROPE: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY END USER, 2022–2029 (USD MILLION)
- TABLE 358 GERMANY: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY OFFERING, 2022–2029 (USD MILLION)
- TABLE 359 GERMANY: HIGH-THROUGHPUT SCREENING (HTS) CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 360 GERMANY: HIGH-THROUGHPUT SCREENING (HTS) INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 361 GERMANY: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
- TABLE 362 GERMANY: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR CELL-BASED ASSAYS, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 363 GERMANY: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR 3D CELL CULTURES, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 364 GERMANY: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SCAFFOLD-BASED TECHNOLOGY, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 365 GERMANY: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR HYDROGELS, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 366 GERMANY: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR ANIMAL-DERIVED HYDROGELS, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 367 GERMANY: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SCAFFOLD-FREE TECHNOLOGY, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 368 GERMANY: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
- TABLE 369 GERMANY: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY END USER, 2022–2029 (USD MILLION)
- TABLE 370 UK: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY OFFERING, 2022–2029 (USD MILLION)
- TABLE 371 UK: HIGH-THROUGHPUT SCREENING (HTS) CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 372 UK: HIGH-THROUGHPUT SCREENING (HTS) INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 373 UK: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
- TABLE 374 UK: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR CELL-BASED ASSAYS, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 375 UK: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR 3D CELL CULTURES, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 376 UK: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SCAFFOLD-BASED TECHNOLOGY, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 377 UK: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR HYDROGELS, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 378 UK: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR ANIMAL-DERIVED HYDROGELS, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 379 UK: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SCAFFOLD-FREE TECHNOLOGY, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 380 UK: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
- TABLE 381 UK: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY END USER, 2022–2029 (USD MILLION)
- TABLE 382 FRANCE: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY OFFERING, 2022–2029 (USD MILLION)
- TABLE 383 FRANCE: HIGH-THROUGHPUT SCREENING (HTS) CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 384 FRANCE: HIGH-THROUGHPUT SCREENING (HTS) INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 385 FRANCE: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
- TABLE 386 FRANCE: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR CELL-BASED ASSAYS, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 387 FRANCE: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR 3D CELL CULTURES, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 388 FRANCE: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SCAFFOLD-BASED TECHNOLOGY, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 389 FRANCE: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR HYDROGELS, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 390 FRANCE: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR ANIMAL-DERIVED HYDROGELS, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 391 FRANCE: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SCAFFOLD-FREE TECHNOLOGY, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 392 FRANCE: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
- TABLE 393 FRANCE: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY END USER, 2022–2029 (USD MILLION)
- TABLE 394 ITALY: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY OFFERING, 2022–2029 (USD MILLION)
- TABLE 395 ITALY: HIGH-THROUGHPUT SCREENING (HTS) CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 396 ITALY: HIGH-THROUGHPUT SCREENING (HTS) INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 397 ITALY: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
- TABLE 398 ITALY: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR CELL-BASED ASSAYS, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 399 ITALY: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR 3D CELL CULTURES, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 400 ITALY: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SCAFFOLD-BASED TECHNOLOGY, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 401 ITALY: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR HYDROGELS, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 402 ITALY: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR ANIMAL-DERIVED HYDROGELS, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 403 ITALY: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SCAFFOLD-FREE TECHNOLOGY, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 404 ITALY: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
- TABLE 405 ITALY: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY END USER, 2022–2029 (USD MILLION)
- TABLE 406 SPAIN: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY OFFERING, 2022–2029 (USD MILLION)
- TABLE 407 SPAIN: HIGH-THROUGHPUT SCREENING (HTS) CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 408 SPAIN: HIGH-THROUGHPUT SCREENING (HTS) INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 409 SPAIN: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
- TABLE 410 SPAIN: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR CELL-BASED ASSAYS, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 411 SPAIN: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR 3D CELL CULTURES, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 412 SPAIN: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SCAFFOLD-BASED TECHNOLOGY, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 413 SPAIN: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR HYDROGELS, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 414 SPAIN: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR ANIMAL-DERIVED HYDROGELS, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 415 SPAIN: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SCAFFOLD-FREE TECHNOLOGY, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 416 SPAIN: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
- TABLE 417 SPAIN: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY END USER, 2022–2029 (USD MILLION)
- TABLE 418 REST OF EUROPE: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY OFFERING, 2022–2029 (USD MILLION)
- TABLE 419 REST OF EUROPE: HIGH-THROUGHPUT SCREENING (HTS) CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 420 REST OF EUROPE: HIGH-THROUGHPUT SCREENING (HTS) INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 421 REST OF EUROPE: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
- TABLE 422 REST OF EUROPE: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR CELL-BASED ASSAYS, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 423 REST OF EUROPE: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR 3D CELL CULTURES, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 424 REST OF EUROPE: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SCAFFOLD-BASED TECHNOLOGY, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 425 REST OF EUROPE: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR HYDROGELS, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 426 REST OF EUROPE: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR ANIMAL-DERIVED HYDROGELS, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 427 REST OF EUROPE: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SCAFFOLD-FREE TECHNOLOGY, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 428 REST OF EUROPE: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
- TABLE 429 REST OF EUROPE: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY END USER, 2022–2029 (USD MILLION)
- TABLE 430 ASIA PACIFIC: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
- TABLE 431 ASIA PACIFIC: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY OFFERING, 2022–2029 (USD MILLION)
- TABLE 432 ASIA PACIFIC: HIGH-THROUGHPUT SCREENING (HTS) CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 433 ASIA PACIFIC: HIGH-THROUGHPUT SCREENING (HTS) INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 434 ASIA PACIFIC: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
- TABLE 435 ASIA PACIFIC: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR CELL-BASED ASSAYS, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 436 ASIA PACIFIC: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR 3D CELL CULTURES, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 437 ASIA PACIFIC: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SCAFFOLD-BASED TECHNOLOGY, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 438 ASIA PACIFIC: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR HYDROGELS, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 439 ASIA PACIFIC: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR ANIMAL-DERIVED HYDROGELS, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 440 ASIA PACIFIC: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SCAFFOLD-FREE TECHNOLOGY, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 441 ASIA PACIFIC: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
- TABLE 442 ASIA PACIFIC: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY END USER, 2022–2029 (USD MILLION)
- TABLE 443 CHINA: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY OFFERING, 2022–2029 (USD MILLION)
- TABLE 444 CHINA: HIGH-THROUGHPUT SCREENING (HTS) CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 445 CHINA: HIGH-THROUGHPUT SCREENING (HTS) INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 446 CHINA: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
- TABLE 447 CHINA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR CELL-BASED ASSAYS, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 448 CHINA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR 3D CELL CULTURES, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 449 CHINA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SCAFFOLD-BASED TECHNOLOGY, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 450 CHINA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR HYDROGELS, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 451 CHINA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR ANIMAL-DERIVED HYDROGELS, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 452 CHINA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SCAFFOLD-FREE TECHNOLOGY, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 453 CHINA: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
- TABLE 454 CHINA: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY END USER, 2022–2029 (USD MILLION)
- TABLE 455 JAPAN: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY OFFERING, 2022–2029 (USD MILLION)
- TABLE 456 JAPAN: HIGH-THROUGHPUT SCREENING (HTS) CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 457 JAPAN: HIGH-THROUGHPUT SCREENING (HTS) INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 458 JAPAN: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
- TABLE 459 JAPAN: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR CELL-BASED ASSAYS, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 460 JAPAN: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR 3D CELL CULTURES, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 461 JAPAN: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SCAFFOLD-BASED TECHNOLOGY, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 462 JAPAN: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR HYDROGELS, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 463 JAPAN: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR ANIMAL-DERIVED HYDROGELS, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 464 JAPAN: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SCAFFOLD-FREE TECHNOLOGY, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 465 JAPAN: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
- TABLE 466 JAPAN: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY END USER, 2022–2029 (USD MILLION)
- TABLE 467 INDIA: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY OFFERING, 2022–2029 (USD MILLION)
- TABLE 468 INDIA: HIGH-THROUGHPUT SCREENING (HTS) CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 469 INDIA: HIGH-THROUGHPUT SCREENING (HTS) INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 470 INDIA: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
- TABLE 471 INDIA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR CELL-BASED ASSAYS, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 472 INDIA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR 3D CELL CULTURES, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 473 INDIA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SCAFFOLD-BASED TECHNOLOGY, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 474 INDIA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR HYDROGELS, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 475 INDIA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR ANIMAL-DERIVED HYDROGELS, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 476 INDIA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SCAFFOLD-FREE TECHNOLOGY, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 477 INDIA: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
- TABLE 478 INDIA: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY END USER, 2022–2029 (USD MILLION)
- TABLE 479 AUSTRALIA: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY OFFERING, 2022–2029 (USD MILLION)
- TABLE 480 AUSTRALIA: HIGH-THROUGHPUT SCREENING (HTS) CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 481 AUSTRALIA: HIGH-THROUGHPUT SCREENING (HTS) INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 482 AUSTRALIA: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
- TABLE 483 AUSTRALIA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR CELL-BASED ASSAYS, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 484 AUSTRALIA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR 3D CELL CULTURES, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 485 AUSTRALIA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SCAFFOLD-BASED TECHNOLOGY, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 486 AUSTRALIA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR HYDROGELS, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 487 AUSTRALIA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR ANIMAL-DERIVED HYDROGELS, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 488 AUSTRALIA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SCAFFOLD-FREE TECHNOLOGY, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 489 AUSTRALIA: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
- TABLE 490 AUSTRALIA: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY END USER, 2022–2029 (USD MILLION)
- TABLE 491 SOUTH KOREA: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY OFFERING, 2022–2029 (USD MILLION)
- TABLE 492 SOUTH KOREA: HIGH-THROUGHPUT SCREENING (HTS) CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 493 SOUTH KOREA: HIGH-THROUGHPUT SCREENING (HTS) INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 494 SOUTH KOREA: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
- TABLE 495 SOUTH KOREA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR CELL-BASED ASSAYS, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 496 SOUTH KOREA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR 3D CELL CULTURES, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 497 SOUTH KOREA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SCAFFOLD-BASED TECHNOLOGY, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 498 SOUTH KOREA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR HYDROGELS, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 499 SOUTH KOREA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR ANIMAL-DERIVED HYDROGELS, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 500 SOUTH KOREA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SCAFFOLD-FREE TECHNOLOGY, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 501 SOUTH KOREA: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
- TABLE 502 SOUTH KOREA: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY END USER, 2022–2029 (USD MILLION)
- TABLE 503 REST OF ASIA PACIFIC: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY OFFERING, 2022–2029 (USD MILLION)
- TABLE 504 REST OF ASIA PACIFIC: HIGH-THROUGHPUT SCREENING (HTS) CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 505 REST OF ASIA PACIFIC: HIGH-THROUGHPUT SCREENING (HTS) INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 506 REST OF ASIA PACIFIC: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
- TABLE 507 REST OF ASIA PACIFIC: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR CELL-BASED ASSAYS, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 508 REST OF ASIA PACIFIC: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR 3D CELL CULTURES, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 509 REST OF ASIA PACIFIC: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SCAFFOLD-BASED TECHNOLOGY, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 510 REST OF ASIA PACIFIC: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR HYDROGELS, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 511 REST OF ASIA PACIFIC: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR ANIMAL-DERIVED HYDROGELS, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 512 REST OF ASIA PACIFIC: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SCAFFOLD-FREE TECHNOLOGY, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 513 REST OF ASIA PACIFIC: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
- TABLE 514 REST OF ASIA PACIFIC: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY END USER, 2022–2029 (USD MILLION)
- TABLE 515 LATIN AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
- TABLE 516 LATIN AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY OFFERING, 2022–2029 (USD MILLION)
- TABLE 517 LATIN AMERICA: HIGH-THROUGHPUT SCREENING (HTS) CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 518 LATIN AMERICA: HIGH-THROUGHPUT SCREENING (HTS) INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 519 LATIN AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
- TABLE 520 LATIN AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR CELL-BASED ASSAYS, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 521 LATIN AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR 3D CELL CULTURES, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 522 LATIN AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SCAFFOLD-BASED TECHNOLOGY, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 523 LATIN AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR HYDROGELS, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 524 LATIN AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR ANIMAL-DERIVED HYDROGELS, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 525 LATIN AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SCAFFOLD-FREE TECHNOLOGY, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 526 LATIN AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
- TABLE 527 LATIN AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY END USER, 2022–2029 (USD MILLION)
- TABLE 528 BRAZIL: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY OFFERING, 2022–2029 (USD MILLION)
- TABLE 529 BRAZIL: HIGH-THROUGHPUT SCREENING (HTS) CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 530 BRAZIL: HIGH-THROUGHPUT SCREENING (HTS) INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 531 BRAZIL: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
- TABLE 532 BRAZIL: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR CELL-BASED ASSAYS, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 533 BRAZIL: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR 3D CELL CULTURES, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 534 BRAZIL: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SCAFFOLD-BASED TECHNOLOGY, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 535 BRAZIL: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR HYDROGELS, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 536 BRAZIL: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR ANIMAL-DERIVED HYDROGELS, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 537 BRAZIL: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SCAFFOLD-FREE TECHNOLOGY, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 538 BRAZIL: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
- TABLE 539 BRAZIL: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY END USER, 2022–2029 (USD MILLION)
- TABLE 540 MEXICO: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY OFFERING, 2022–2029 (USD MILLION)
- TABLE 541 MEXICO: HIGH-THROUGHPUT SCREENING (HTS) CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 542 MEXICO: HIGH-THROUGHPUT SCREENING (HTS) INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 543 MEXICO: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
- TABLE 544 MEXICO: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR CELL-BASED ASSAYS, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 545 MEXICO: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR 3D CELL CULTURES, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 546 MEXICO: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SCAFFOLD-BASED TECHNOLOGY, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 547 MEXICO: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR HYDROGELS, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 548 MEXICO: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR ANIMAL-DERIVED HYDROGELS, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 549 MEXICO: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SCAFFOLD-FREE TECHNOLOGY, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 550 MEXICO: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
- TABLE 551 MEXICO: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY END USER, 2022–2029 (USD MILLION)
- TABLE 552 REST OF LATIN AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY OFFERING, 2022–2029 (USD MILLION)
- TABLE 553 REST OF LATIN AMERICA: HIGH-THROUGHPUT SCREENING (HTS) CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 554 REST OF LATIN AMERICA: HIGH-THROUGHPUT SCREENING (HTS) INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 555 REST OF LATIN AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
- TABLE 556 REST OF LATIN AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR CELL-BASED ASSAYS, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 557 REST OF LATIN AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR 3D CELL CULTURES, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 558 REST OF LATIN AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SCAFFOLD-BASED TECHNOLOGY, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 559 REST OF LATIN AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR HYDROGELS, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 560 REST OF LATIN AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR ANIMAL-DERIVED HYDROGELS, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 561 REST OF LATIN AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SCAFFOLD-FREE TECHNOLOGY, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 562 REST OF LATIN AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
- TABLE 563 REST OF LATIN AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY END USER, 2022–2029 (USD MILLION)
- TABLE 564 MIDDLE EAST: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
- TABLE 565 MIDDLE EAST: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY OFFERING, 2022–2029 (USD MILLION)
- TABLE 566 MIDDLE EAST: HIGH-THROUGHPUT SCREENING (HTS) CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 567 MIDDLE EAST: HIGH-THROUGHPUT SCREENING (HTS) INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 568 MIDDLE EAST: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
- TABLE 569 MIDDLE EAST: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR CELL-BASED ASSAYS, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 570 MIDDLE EAST: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR 3D CELL CULTURES, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 571 MIDDLE EAST: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SCAFFOLD-BASED TECHNOLOGY, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 572 MIDDLE EAST: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR HYDROGELS, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 573 MIDDLE EAST: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR ANIMAL-DERIVED HYDROGELS, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 574 MIDDLE EAST: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SCAFFOLD-FREE TECHNOLOGY, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 575 MIDDLE EAST: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
- TABLE 576 MIDDLE EAST: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY END USER, 2022–2029 (USD MILLION)
- TABLE 577 GCC COUNTRIES: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
- TABLE 578 GCC COUNTRIES: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY OFFERING, 2022–2029 (USD MILLION)
- TABLE 579 GCC COUNTRIES: HIGH-THROUGHPUT SCREENING (HTS) CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 580 GCC COUNTRIES: HIGH-THROUGHPUT SCREENING (HTS) INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 581 GCC COUNTRIES: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
- TABLE 582 GCC COUNTRIES: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR CELL-BASED ASSAYS, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 583 GCC COUNTRIES: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR 3D CELL CULTURES, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 584 GCC COUNTRIES: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SCAFFOLD-BASED TECHNOLOGY, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 585 GCC COUNTRIES: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR HYDROGELS, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 586 GCC COUNTRIES: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR ANIMAL-DERIVED HYDROGELS, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 587 GCC COUNTRIES: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SCAFFOLD-FREE TECHNOLOGY, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 588 GCC COUNTRIES: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
- TABLE 589 GCC COUNTRIES: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY END USER, 2022–2029 (USD MILLION)
- TABLE 590 SAUDI ARABIA: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY OFFERING, 2022–2029 (USD MILLION)
- TABLE 591 SAUDI ARABIA: HIGH-THROUGHPUT SCREENING (HTS) CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 592 SAUDI ARABIA: HIGH-THROUGHPUT SCREENING (HTS) INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 593 SAUDI ARABIA: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
- TABLE 594 SAUDI ARABIA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR CELL-BASED ASSAYS, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 595 SAUDI ARABIA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR 3D CELL CULTURES, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 596 SAUDI ARABIA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SCAFFOLD-BASED TECHNOLOGY, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 597 SAUDI ARABIA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR HYDROGELS, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 598 SAUDI ARABIA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR ANIMAL-DERIVED HYDROGELS, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 599 SAUDI ARABIA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SCAFFOLD-FREE TECHNOLOGY, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 600 SAUDI ARABIA: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
- TABLE 601 SAUDI ARABIA: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY END USER, 2022–2029 (USD MILLION)
- TABLE 602 UNITED ARAB EMIRATES: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY OFFERING, 2022–2029 (USD MILLION)
- TABLE 603 UNITED ARAB EMIRATES: HIGH-THROUGHPUT SCREENING (HTS) CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 604 UNITED ARAB EMIRATES: HIGH-THROUGHPUT SCREENING (HTS) INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 605 UNITED ARAB EMIRATES: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
- TABLE 606 UNITED ARAB EMIRATES: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR CELL-BASED ASSAYS, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 607 UNITED ARAB EMIRATES: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR 3D CELL CULTURES, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 608 UNITED ARAB EMIRATES: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SCAFFOLD-BASED TECHNOLOGY, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 609 UNITED ARAB EMIRATES: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR HYDROGELS, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 610 UNITED ARAB EMIRATES: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR ANIMAL-DERIVED HYDROGELS, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 611 UNITED ARAB EMIRATES: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SCAFFOLD-FREE TECHNOLOGY, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 612 UNITED ARAB EMIRATES: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
- TABLE 613 UNITED ARAB EMIRATES: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY END USER, 2022–2029 (USD MILLION)
- TABLE 614 REST OF GCC COUNTRIES: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY OFFERING, 2022–2029 (USD MILLION)
- TABLE 615 REST OF GCC COUNTRIES: HIGH-THROUGHPUT SCREENING (HTS) CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 616 REST OF GCC COUNTRIES: HIGH-THROUGHPUT SCREENING (HTS) INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 617 REST OF GCC COUNTRIES: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
- TABLE 618 REST OF GCC COUNTRIES: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR CELL-BASED ASSAYS, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 619 REST OF GCC COUNTRIES: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR 3D CELL CULTURES, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 620 REST OF GCC COUNTRIES: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SCAFFOLD-BASED TECHNOLOGY, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 621 REST OF GCC COUNTRIES: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR HYDROGELS, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 622 REST OF GCC COUNTRIES: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR ANIMAL-DERIVED HYDROGELS, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 623 REST OF GCC COUNTRIES: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SCAFFOLD-FREE TECHNOLOGY, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 624 REST OF GCC COUNTRIES: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
- TABLE 625 REST OF GCC COUNTRIES: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY END USER, 2022–2029 (USD MILLION)
- TABLE 626 REST OF MIDDLE EAST: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY OFFERING, 2022–2029 (USD MILLION)
- TABLE 627 REST OF MIDDLE EAST: HIGH-THROUGHPUT SCREENING (HTS) CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 628 REST OF MIDDLE EAST: HIGH-THROUGHPUT SCREENING (HTS) INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 629 REST OF MIDDLE EAST: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
- TABLE 630 REST OF MIDDLE EAST: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR CELL-BASED ASSAYS, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 631 REST OF MIDDLE EAST: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR 3D CELL CULTURES, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 632 REST OF MIDDLE EAST: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SCAFFOLD-BASED TECHNOLOGY, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 633 REST OF MIDDLE EAST: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR HYDROGELS, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 634 REST OF MIDDLE EAST: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR ANIMAL-DERIVED HYDROGELS, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 635 REST OF MIDDLE EAST: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SCAFFOLD-FREE TECHNOLOGY, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 636 REST OF MIDDLE EAST: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
- TABLE 637 REST OF MIDDLE EAST: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY END USER, 2022–2029 (USD MILLION)
- TABLE 638 AFRICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY OFFERING, 2022–2029 (USD MILLION)
- TABLE 639 AFRICA: HIGH-THROUGHPUT SCREENING (HTS) CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 640 AFRICA: HIGH-THROUGHPUT SCREENING (HTS) INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 641 AFRICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
- TABLE 642 AFRICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR CELL-BASED ASSAYS, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 643 AFRICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR 3D CELL CULTURES, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 644 AFRICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SCAFFOLD-BASED TECHNOLOGY, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 645 AFRICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR HYDROGELS, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 646 AFRICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR ANIMAL-DERIVED HYDROGELS, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 647 AFRICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SCAFFOLD-FREE TECHNOLOGY, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 648 AFRICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
- TABLE 649 AFRICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY END USER, 2022–2029 (USD MILLION)
- TABLE 650 OVERVIEW OF STRATEGIES DEPLOYED BY KEY PLAYERS IN HIGH-THROUGHPUT SCREENING MARKET
- TABLE 651 HIGH-THROUGHPUT SCREENING (HTS) MARKET: DEGREE OF COMPETITION
- TABLE 652 HIGH-THROUGHPUT SCREENING (HTS) MARKET: OFFERING FOOTPRINT
- TABLE 653 HIGH-THROUGHPUT SCREENING (HTS) MARKET: APPLICATION FOOTPRINT
- TABLE 654 HIGH-THROUGHPUT SCREENING (HTS) MARKET: REGION FOOTPRINT
- TABLE 655 HIGH-THROUGHPUT SCREENING (HTS) MARKET: DETAILED LIST OF KEY STARTUP/SME PLAYERS
- TABLE 656 HIGH-THROUGHPUT SCREENING (HTS) MARKET: COMPETITIVE BENCHMARKING OF KEY EMERGING PLAYERS/STARTUPS
- TABLE 657 HIGH-THROUGHPUT SCREENING (HTS) MARKET: PRODUCT LAUNCHES, JANUARY 2021–MAY 2024
- TABLE 658 HIGH-THROUGHPUT SCREENING (HTS) MARKET: DEALS, JANUARY 2021–MAY 2024
- TABLE 659 HIGH-THROUGHPUT SCREENING (HTS) MARKET: EXPANSIONS, JANUARY 2021–MAY 2024
- TABLE 660 THERMO FISHER SCIENTIFIC INC.: BUSINESS OVERVIEW
- TABLE 661 THERMO FISHER SCIENTIFIC INC.: PRODUCTS & SERVICES OFFERED
- TABLE 662 THERMO FISHER SCIENTIFIC INC.: PRODUCT LAUNCHES & APPROVALS
- TABLE 663 THERMO FISHER SCIENTIFIC INC.: DEALS
- TABLE 664 THERMO FISHER SCIENTIFIC INC.: EXPANSIONS
- TABLE 665 AGILENT TECHNOLOGIES, INC.: BUSINESS OVERVIEW
- TABLE 666 AGILENT TECHNOLOGIES, INC.: PRODUCTS & SERVICES OFFERED
- TABLE 667 AGILENT TECHNOLOGIES, INC.: PRODUCT LAUNCHES & UPGRADES
- TABLE 668 AGILENT TECHNOLOGIES, INC.: DEALS
- TABLE 669 MERCK KGAA: BUSINESS OVERVIEW
- TABLE 670 MERCK KGAA: PRODUCTS & SERVICES OFFERED
- TABLE 671 MERCK KGAA: OTHER DEVELOPMENTS
- TABLE 672 DANAHER CORPORATION: BUSINESS OVERVIEW
- TABLE 673 DANAHER CORPORATION: PRODUCTS & SERVICES OFFERED
- TABLE 674 DANAHER CORPORATION: PRODUCT & SERVICE LAUNCHES
- TABLE 675 DANAHER CORPORATION: DEALS
- TABLE 676 DANAHER CORPORATION: EXPANSIONS
- TABLE 677 REVVITY, INC.: BUSINESS OVERVIEW
- TABLE 678 REVVITY INC.: PRODUCTS & SERVICES OFFERED
- TABLE 679 REVVITY, INC.: PRODUCT LAUNCHES
- TABLE 680 REVVITY, INC.: DEALS
- TABLE 681 TECAN GROUP LTD.: BUSINESS OVERVIEW
- TABLE 682 TECAN GROUP LTD.: PRODUCTS & SERVICES OFFERED
- TABLE 683 TECAN GROUP LTD.: PRODUCT LAUNCHES & UPGRADES
- TABLE 684 TECAN GROUP LTD.: DEALS
- TABLE 685 BIO-RAD LABORATORIES, INC.: BUSINESS OVERVIEW
- TABLE 686 BIO-RAD LABORATORIES, INC.: PRODUCTS & SERVICES OFFERED
- TABLE 687 BIO-RAD LABORATORIES, INC.: PRODUCT LAUNCHES
- TABLE 688 CORNING INCORPORATED: BUSINESS OVERVIEW
- TABLE 689 CORNING INCORPORATED: PRODUCTS & SERVICES OFFERED
- TABLE 690 CORNING INCORPORATED: PRODUCT LAUNCHES
- TABLE 691 METTLER-TOLEDO INTERNATIONAL INC.: BUSINESS OVERVIEW
- TABLE 692 METTLER-TOLEDO INTERNATIONAL INC.: PRODUCTS & SERVICES OFFERED
- TABLE 693 METTLER-TOLEDO INTERNATIONAL INC.: PRODUCT LAUNCHES
- TABLE 694 LONZA GROUP: BUSINESS OVERVIEW
- TABLE 695 LONZA GROUP: PRODUCTS & SERVICES OFFERED
- TABLE 696 LONZA GROUP: DEALS
- TABLE 697 WATERS CORPORATION: BUSINESS OVERVIEW
- TABLE 698 WATERS CORPORATION: PRODUCTS & SERVICES OFFERED
- TABLE 699 WATERS CORPORATION: PRODUCT LAUNCHES
- TABLE 700 WATERS CORPORATION: DEALS
- TABLE 701 SARTORIUS AG: BUSINESS OVERVIEW
- TABLE 702 SARTORIUS AG: PRODUCTS & SERVICES OFFERED
- TABLE 703 SARTORIUS AG: PRODUCT LAUNCHES
- TABLE 704 EPPENDORF SE: BUSINESS OVERVIEW
- TABLE 705 EPPENDORF SE: PRODUCTS & SERVICES OFFERED
- TABLE 706 EPPENDORF SE: DEALS
- TABLE 707 EPPENDORF SE: EXPANSIONS
- TABLE 708 PORVAIR PLC: BUSINESS OVERVIEW
- TABLE 709 PORVAIR PLC: PRODUCTS & SERVICES OFFERED
- TABLE 710 GREINER AG: BUSINESS OVERVIEW
- TABLE 711 GREINER AG: PRODUCTS & SERVICES OFFERED
- TABLE 712 CHARLES RIVER LABORATORIES INTERNATIONAL, INC.: BUSINESS OVERVIEW
- TABLE 713 CHARLES RIVER LABORATORIES INTERNATIONAL, INC.: PRODUCTS & SERVICES OFFERED
- TABLE 714 CHARLES RIVER LABORATORIES INTERNATIONAL, INC.: DEALS
- TABLE 715 EUROFINS SCIENTIFIC: BUSINESS OVERVIEW
- TABLE 716 EUROFINS SCIENTIFIC: PRODUCTS & SERVICES OFFERED
- TABLE 717 EUROFINS SCIENTIFIC: SERVICE LAUNCHES
- TABLE 718 EUROFINS SCIENTIFIC: DEALS
- TABLE 719 EUROFINS SCIENTIFIC: EXPANSIONS
- TABLE 720 HAMILTON COMPANY: BUSINESS OVERVIEW
- TABLE 721 HAMILTON COMPANY: PRODUCTS & SERVICES OFFERED
- TABLE 722 HAMILTON COMPANY: PRODUCT LAUNCHES
- TABLE 723 HAMILTON COMPANY: DEALS
- TABLE 724 AURORA BIOMED INC.: BUSINESS OVERVIEW
- TABLE 725 AURORA BIOMED INC.: PRODUCTS & SERVICES OFFERED
- TABLE 726 GILSON INCORPORATED: BUSINESS OVERVIEW
- TABLE 727 GILSON INCORPORATED: PRODUCTS & SERVICES OFFERED
- TABLE 728 GILSON INCORPORATED.: PRODUCT LAUNCHES
- TABLE 729 GILSON INCORPORATED: DEALS
- TABLE 730 BRAND GMBH + CO KG: BUSINESS OVERVIEW
- TABLE 731 BRAND GMBH + CO KG: PRODUCTS & SERVICES OFFERED
- TABLE 732 BRAND GMBH + CO KG: EXPANSIONS
List of Figures
- FIGURE 1 HIGH-THROUGHPUT SCREENING (HTS) MARKET SEGMENTATION
- FIGURE 2 RESEARCH DESIGN
- FIGURE 3 HIGH-THROUGHPUT SCREENING (HTS) MARKET: BREAKDOWN OF PRIMARIES
- FIGURE 4 MARKET SIZE ESTIMATION: SUPPLY-SIDE ANALYSIS, 2023
- FIGURE 5 MARKET SIZE ESTIMATION: APPROACH 1 (REVENUE SHARE ANALYSIS), 2023
- FIGURE 6 ILLUSTRATIVE EXAMPLE OF THERMO FISHER SCIENTIFIC INC.: REVENUE SHARE ANALYSIS, 2023
- FIGURE 7 MARKET VALIDATION FROM PRIMARY EXPERTS
- FIGURE 8 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH
- FIGURE 9 HIGH-THROUGHPUT SCREENING (HTS) MARKET: CAGR PROJECTIONS, 2024–2029
- FIGURE 10 HIGH-THROUGHPUT SCREENING (HTS) MARKET: GROWTH ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
- FIGURE 11 DATA TRIANGULATION METHODOLOGY
- FIGURE 12 HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY OFFERING, 2024 VS. 2029 (USD MILLION)
- FIGURE 13 HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY TECHNOLOGY, 2024 VS. 2029 (USD MILLION)
- FIGURE 14 HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY APPLICATION, 2024 VS. 2029 (USD MILLION)
- FIGURE 15 HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY END USER, 2024 VS. 2029 (USD MILLION)
- FIGURE 16 GEOGRAPHICAL SNAPSHOT: HIGH-THROUGHPUT SCREENING (HTS) MARKET
- FIGURE 17 GROWING ADOPTION OF OPEN INNOVATIVE MODELS IN PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES TO DRIVE MARKET GROWTH
- FIGURE 18 CONSUMABLES DOMINATED NORTH AMERICAN HIGH-THROUGHPUT SCREENING (HTS) MARKET IN 2023
- FIGURE 19 CONSUMABLES TO CONTINUE TO DOMINATE MARKET BY 2029
- FIGURE 20 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES ACCOUNTED FOR LARGEST MARKET SHARE IN 2023
- FIGURE 21 ASIA PACIFIC TO REGISTER HIGHEST GROWTH RATE IN HIGH-THROUGHPUT SCREENING (HTS) MARKET FROM 2024 TO 2029
- FIGURE 22 HIGH-THROUGHPUT SCREENING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
- FIGURE 23 RISING GLOBAL PHARMACEUTICAL R&D SPENDING, 2014–2028
- FIGURE 24 REVENUE SHIFT & NEW POCKETS FOR HIGH-THROUGHPUT SCREENING (HTS) SOLUTION PROVIDERS
- FIGURE 25 PRICING TREND FOR INSTRUMENTS, 2021–2023
- FIGURE 26 VALUE CHAIN ANALYSIS: MAJOR VALUE IS ADDED DURING PRODUCT DEVELOPMENT PHASE
- FIGURE 27 DIRECT DISTRIBUTION—STRATEGY PREFERRED BY PROMINENT COMPANIES
- FIGURE 28 ECOSYSTEM ANALYSIS: HIGH-THROUGHPUT SCREENING MARKET
- FIGURE 29 TOP APPLICANTS & OWNERS (COMPANIES) FOR HIGH-THROUGHPUT SCREENING PATENTS (JANUARY 2012–DECEMBER 2023)
- FIGURE 30 HIGH-THROUGHPUT SCREENING MARKET: PORTER'S FIVE FORCES ANALYSIS
- FIGURE 31 KEY BUYING CRITERIA FOR END USERS
- FIGURE 32 NORTH AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET SNAPSHOT
- FIGURE 33 ASIA PACIFIC: HIGHT-THROUGHPUT SCREENING (HTS) MARKET SNAPSHOT
- FIGURE 34 REVENUE ANALYSIS OF KEY PLAYERS, 2021–2023 (USD MILLION)
- FIGURE 35 MARKET SHARE ANALYSIS OF KEY PLAYERS, 2023
- FIGURE 36 HIGH-THROUGHPUT SCREENING (HTS) MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023
- FIGURE 37 HIGH-THROUGHPUT SCREENING (HTS) MARKET: COMPANY FOOTPRINT
- FIGURE 38 HIGH-THROUGHPUT SCREENING (HTS) MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2023
- FIGURE 39 EV/EBITDA OF KEY VENDORS
- FIGURE 40 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS
- FIGURE 41 HIGH-THROUGHPUT SCREENING (HTS) MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS
- FIGURE 42 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2023)
- FIGURE 43 AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT (2023)
- FIGURE 44 MERCK KGAA: COMPANY SNAPSHOT (2023)
- FIGURE 45 DANAHER CORPORATION: COMPANY SNAPSHOT (2023)
- FIGURE 46 REVVITY, INC.: COMPANY SNAPSHOT (2023)
- FIGURE 47 TECAN GROUP LTD. COMPANY SNAPSHOT (2023)
- FIGURE 48 BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT (2023)
- FIGURE 49 CORNING INCORPORATED: COMPANY SNAPSHOT (2023)
- FIGURE 50 METTLER-TOLEDO INTERNATIONAL INC.: COMPANY SNAPSHOT (2023)
- FIGURE 51 LONZA GROUP: COMPANY SNAPSHOT (2023)
- FIGURE 52 WATERS CORPORATION: COMPANY SNAPSHOT (2023)
- FIGURE 53 SARTORIUS AG: COMPANY SNAPSHOT (2023)
- FIGURE 54 EPPENDORF SE: COMPANY SNAPSHOT (2023)
- FIGURE 55 PORVAIR PLC: COMPANY SNAPSHOT (2023)
- FIGURE 56 GREINER AG: COMPANY SNAPSHOT (2023)
- FIGURE 57 CHARLES RIVER LABORATORIES INTERNATIONAL, INC.: COMPANY SNAPSHOT (2023)
- FIGURE 58 EUROFINS SCIENTIFIC: COMPANY SNAPSHOT (2023)
02-2729-4219
+886-2-2729-4219
高通量篩選市場、佔有率、規模、趨勢、行業分析報告：按產品、按技術、按應用、按最終用戶、按地區 - 市場預測，2024-2032 年
高通量篩檢市場規模、佔有率和趨勢分析報告：2024-2030 年按產品/服務、技術、應用、最終用途、地區和細分市場進行的預測
高通量製程發展市場:全球產業分析，規模，佔有率，成長，趨勢，預測，2024-2033年
高吞吐量分類機市場，按產品類型、應用、國家和地區 - 2024-2032 年行業分析、市場規模、市場佔有率和預測
高通量篩檢(HTS)服務的全球市場的考察，預測(～2030年)
高通量篩選市場預測：~2030 年
2024 年高通量篩檢(HTS) 全球市場報告
到 2030 年高通量分類機市場預測：按類型、應用和地區分類的全球分析
到 2030 年高通量篩選市場預測：按產品、技術、應用、最終用戶和地區分類的全球分析
2024-2028 年全球高通量篩選 (HTS) 市場
▼